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OCCURRENCE, FATE AND EFFECTS OF PHARMACEUTICALS AND 
HORMONES IN AQUATIC ENVIRONMENT 
SUMMARY 
The aim of this study is to provide specific information on the occurrence, fate and 
effects of pharmaceuticals and hormones in aquatic environment.  10 widely used 
pharmaceuticals (three NSAIDs, Diclofenac, Ibuprofen, Naproxen; four antibiotics 
amoxicillin, ciprofloxacin, erythromycin, and sulfamethoxazole; two β-blockers, 
atenolol and propranolol; and one stimulant, caffeine and 4 estrogen hormones 
estrone (E1), estradiol (E2), estriol (E3), and 17α-ethynylestradiol (EE2) were 
selected according to one year-sales data.  The occurrence of selected 
pharmaceuticals and hormones in surface water in Istanbul, Turkey was investigated 
in this study. An important drinking water source, Büyükçekmece Lake and five 
main rivers flowing into the lake were selected for the monitoring of the compounds. 
Sampling was conducted five different times in a year in order to observe seasonal 
changes. A new, rapid and sensitive method using solid phase extraction and ultra-
performance liquid chromatograph coupled with triple quadrupole tandem mass 
spectrometer was developed. Minimum quantification limits were between 0.5 and 
1.1 ng/L for different compounds. Recoveries were between 72-119 % and 61-98 % 
for ultra-pure water and for surface water, respectively. All selected compounds were 
detected at least once in the samples. Some pharmaceuticals were detected as high as 
a few of micrograms per liter levels in the rivers. Most frequently detected 
compounds were caffeine and antibiotics (amoxicillin, ciprofloxacin, erythromycin 
and sulfamethoxazole). Synthetic hormone (17α-ethynylestradiol) was detected only 
4 times making it the least detected compound in the whole sampling period. 
Since pharmaceuticals are designed to exert biological effects, it is expected that they 
adversely affect ecosystem.  Moreover, they may pose threat to human health via 
food web and/or direct exposure.  Different tools were used for the determination of 
ecological impacts of selected pharmaceuticals and hormones to cover different 
effects and to understand responses of different species in different levels of the food 
web.  P. subcapitata was used for the determination of acute effects whereas D. 
magna was used for the determination of both acute and chronic effects.  Mutagenic 
effects and endocrine disruptive effects were determined with AMES and YES test, 
respectively.   
The results of tests conducted with P. subcapitata and D. magna indicate that even 
though studied pharmaceuticals and hormones may not present acute adverse effects 
at low concentrations; they may have drastic chronic effects.  
In addition to studying the effects of single compounds, the effects of mixtures of 
pharmaceutical and hormones were also studied since there was a lack of data in the 
scientific literature. All mixtures had synergistic interaction for D. magna acute 
immobilization, P. subcapitata growth inhibition, and D. magna reproduction 
inhibition tests.  Moreover, mixtures had stronger toxicity than predicted values even 
xx 
at concentrations at which single compounds do not exhibit effects for D. magna 
acute immobilization, P. subcapitata growth inhibition, and D. magna reproduction 
inhibition tests.  These results indicate that NOECs for single toxicity tests are not 
enough for the assessment of environmental risks of the compounds since they will 
be present as a mixture.   
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SUCUL ORTAMLARDA İLAÇ VE HORMONLARIN SAPTANMASI, 
DAVRANIŞ VE ETKİLERİ 
ÖZET 
1960’ların ortalarından başlayarak PCBler, DDT ve metil civa gibi kirleticilerin 
zehirlilik etkilerinin ve besin zincirinde üst basamaklara çıkıldıkça canlılarda daha 
fazla biriktiğinin belirlenmesi ile kirleticilerin ekosistem üzerindeki zararlı etkileri ve 
çevredeki değişimleri konusundaki çalışmalar giderek artmaya başlamıştır. Bu tip 
tekil kimyasalların KOİ ve BOİ gibi kolektif organik parametrelerden farklı olarak 
tanımlanabilmesi için “özel su kirleticileri” (specific water pollutants) kavramı ortaya 
atılmıştır. OECD’nin yaptığı tanıma göre belirli koşullar altında suyun kalitesini 
özellikle insana ve su canlılarına olan zehirli etkisi nedeniyle çok düşük 
konsantrasyonlarda dahi düşüren ve insan faaliyetleri sonucu çevreye karışan 
maddelere özel su kirleticileri ya da kalıcı kirleticiler ya da mikrokirleticiler 
denilmektedir. Teknolojinin gelişmesi ile birlikte hem mikrokirleticiler, çevresel 
sularda daha düşük ölçüm limitlerinde ölçülebilir olmuş hem de canlı yaşamını ve 
ekosistem dengesini etkileyebilecek yeni kirleticiler ortaya konulmuştur. Bu tip 
kirleticiler henüz yönetmelikler ile denetlenmediği için görünür hale gelen 
anlamındaki “emerging pollutants” adı altında kategorileştirilmişlerdir. “Emerging 
pollutants” içerisinde yüzey aktif maddeler, ilaçlar ve kişisel bakım ürünleri 
sayılabilir. Bu kategorideki birçok kirletici için henüz risk değerlendirmesinde 
kullanılabilecek çevresel konsantrasyon ve ekotoksikolojik veriler yeterince 
bulunmamaktadır. Dolayısıyla bu kirleticilerin canlı yaşamına ve ekosisteme 
etkilerini eldeki veriler ile kestirmek çok zordur ve iyi bir değerlendirme için yeni 
verilere ihtiyaç bulunmaktadır.  
İlaçların önemli bir olası etkisi ise maruz kalan canlıların endokrin sisteminin 
işlevinde yaratacağı bozuklukardır.  “Endokrin sistemi bozucu” terimi ilk kez 
1992’de kullanılmış olup 1996’da ABD’de bu tür maddelerin neler olabileceğine dair 
resmi araştırmalar yapılmaya başlanmıştır.   
Önemli bir çevresel sorun olan ilaç kalıntıları Avrupa Birliği 5. Çerçeve 
Programı’nda araştırma önceliğine sahip alan olarak seçilmiş olup Avrupa Birliği’nin 
bu konudaki araştırmalara desteği 6. ve 7. Çerçeve Programları’nda da devam 
etmiştir.  
İlaçların üretim ve kullanımları çevrede birikmelerine ve ekosistemin ilaçlardan 
etkilenmesine neden olur.  İlaçların en önemli kaynakları hasta kullanımları 
sonucunda evler ve hastanelerdir. Kullanım sonrası ilaçlar vücuttan değişmeden ya 
da metabolit ya da konjugeleri şeklinde atılırlar. 
Aıtksu arıtma tesisleri ise ilaç ve endokrin sistemi bozucu maddeleri taşıyan 
atıksuların toplandığı yerlerdir.  Atıksu arıtma tesisleri genellikle Kimyasal Oksijen 
İhtiyacı deneyi ile tespit edilebilen karbonlu organik maddelerin ve azot ve fosfor 
gibi besi maddelerinin giderimi için tasarlanmıştırlar. Birçok ilaç biyolojik olarak 
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parçalanamadığı için atıksu arıtma tesisleri ilaç ve endokrin sistemi bozucu 
maddelerin esas kaynağı olarak kabul edilebilir. 
Tarım ve hayvancılık faaliyetleri ile balık çiftlikleri ilaç ve hormonların yayılı 
kaynaklarıdır. Estrojenler ve diğer ilaçlar balık çiftliklerinde üremeyi artırmak için 
kullanılırlar.  Balık çiftlikleri denizlere kuruldukları için bu tesislerde kullanılan ilaç 
ve hormonlar tesisin bulunduğu alanı kirletirler.  Yetiştirilen hayvanlara da çeşitli 
ilaç ve hormonlar verilmektedir.  Kullanılan bu ilaç ve hormonlar hayvan 
vücudundan dışkı ile atıldıktan sonra yüzeysel akış yolu ile yüzeysel sulara 
ulaşmaktadır. 
İlaçların ve hormonların çevresel sulardaki miktarlarının belirlenmesi son derece 
kompleks matrislere sahip numunelerde çok hassas ölçümleri gerektirmektedir. Bu 
sebeple, kullanılan analitik teknikler, ölçümü yapılan maddelerin birçok safsızlıkların 
arasından ayrılıp belirlenmesini sağlayacak kadar spesifik, düşük ölçüm limitlerine 
inebilecek kadar da hassas olmalıdır. İlaçların birçoğu polar yapıda olup görece daha 
düşük moleküler ağırlıklara sahip oldukları için ölçümleri son derece zorlayıcı 
olabilir. Bu yüzden ilaçların çevresel sulardaki miktarlarının belirlenmesi ileri ölçüm 
tekniklerinin (GC-MS/MS, LC-MS/MS gibi) kullanımını gerektirmektedir. 
Hâlihazırda ilaçların ölçümünü amaçlayan metotlar literatürde yer almakta ve bu 
metotların sayıları hızla artmaktadır ancak yine de kullanılagelen bu analitik 
metotların geliştirilmesi gerekmektedir. 
İlaç ve hormonların ekolojik etkileri ng/L seviyelerinde görüldüğü için ölçüm 
limitlerinin de bu seviyelerde olması gerekmektedir.  Önceleri GC-MS ve GC-
MS/MS ilaç ve hormonların kullanımları için tercih edilen ekipmanlar iken gelişen 
teknoloji ile hassasiyetleri artırılan ve türevlendirme gerektirmeyen LC-MS/MS 
sistemler bu çalışmalarda günümüzde daha sık kullanılmaktadır. 
Kirleticilerin çevredeki değişim ve dönüşümlerinin belirlenmesi karmaşık bir 
konudur.  Değişim ve taşınım prosesleri çalışılan matrise bağlıdır.  Genellikle, 
değişim ve dönüşüm çalışmalarında iki temel yaklaşım kullanılmaktadır: laboratuvar 
ölçekli çalışmalar ile saha çalışmaları. Laboratuvar çalışmaları tüm proseslerin belirli 
bir detayı hakkında bilgi sağlarken saha çalışmaları gerçek koşullar altında, 
kirleticilerin davranışı hakkında açıklama yapılmasına olanak sağlarlar. 
İlaçlar biyolojik bir etki yaratmak üzere tasarlandıkları için ekosistemlere ve 
özellikle bu ekosistemlerde yaşayan canlılara ters yönde etki edecekleri tahmin 
edilmektedir.  Her ne kadar çevrede bulunduklarından daha yüksek dozlarda ilaçlar 
tedavi için kullanılsa da besin zinciri aracılığıyla ya da içme suyundan doğrudan 
maruz kalma ile sulardaki ilaç kalıntıları uzun maruz kalma süreleri sonucu insan 
sağlığını da tehdit edebilir.  
Ekolojik etki belirleme çalışmalarında genellikle tek bir tür üzerinde yapılan 
deneyler kullanılmaktadır.  Ancak bu tip deneyler türlerin etkileşimi hakkında 
minimum bilgi sağlamaktadır.  Besin zinciri boyunca etki mekanizmasını belirlemek 
için bensin zincirinin farklı basamaklarında bulunan farklı türler kullanılmalıdır.  
Yürürlükteki yasalara göre, yeni bir ilaç piyasaya sürülmeden önce akut ve kronik 
etkileri belirlenmelidir. Dolayısıyla ilaçların etkileri hakkında ilaç piyasaya 
sürülmeden çeşitli testler yapılır. Ancak, literatürde, ilaçların interaktif 
(sinerjistik/antogonistik v.b.) etkileri hakkında bazı çalışmalar olsa da bu etkiler hala 
yeterince ortaya konamamıştır.  
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Endokrin bozucu maddelerin ve ilaçların kütle tabanlı analitik cihazlar ile ölçümü 
kantitatif sonuçlar vermektedir. Diğer yandan daha kalitatif olan biyolojik testler ise 
toplam östrojenik etkiyi vermesi açısından son derece etkin araçlardır. Her iki 
sistemin kendine özgü avantaj ve dezavantajları ortaya konulduğu zaman hem 
estrojeniteyi belirlemek açısında biyolojik testlerin (YES vb.) hem de izlenen 
maddelerin çevresel konsantasyonlarının belirlenmesi açısından analitik ölçüm 
cihazlarının (LC-MS/MS) kullanımı çalışmalarda farklı bakış açıları ile 
değerlendirmeler yapılmasını sağlamaktadır. 
Özellikle gelişmiş ülkelerde ilaç ve hormonların yüzeysel sulardaki miktarları ile 
ilgili çeşitli çalışmalar bulunmaktadır. Yine de ilaç ve hormonların yüzeysel 
sulardaki davranışlarının belirlenmesi için yeni saha çalışmalarına gereksinim 
duyulmaktadır.   
Bu çalışmanın temel amacı sucul ortamlardaki ilaç ve hormon kalıntılarının varlığı, 
değişimi ve etkileri üzerine bilimsel bilgi oluşturmaktır.  Çok fazla kullanılan 10 adet 
ilaç etken maddesi (3 adet steroid olmayan ateş düşürücü, diklofenak, ibuprofen, 
naproksen; 4 adet antibiyotik, amoksisilin, siprofloxasin, eritromisin ve 
sulfametoksazol; 2 adet beta bloker, atenolol ve propranolol ve bir adet uyarıcı, 
kafein) ve 4 adet östrojen hormon estrone (E1), estradiol (E2), estriol (E3), ve 17α-
ethynylestradiol (EE2) bir yıllık satış verilerine gore seçilmiştir.  Seçilen ilaç ve 
hormon kalıntılarının İstanbul’da bulunan bir yüzeysel sudaki varlığı araştırılmıştır.   
Önemli bir içme suyu kaynağı olan Büyükçekmece Gölü ve bu göle akan beş adet 
derede seçilen ilaçların anlık konsantrasyonları izlenmiştir.  Mevsimsel değişimleri 
izlemek amacıyla yılın beş farklı zamanında numune alınmıştır.  Katı faz 
ekstraksiyonu ve tandem kütle spektroskopisine bağlı ultra performanslı sıvı 
kromatograf kullanılarak hızlı ve hassas bir ölçüm yöntemi geliştirilmiştir.  
Maddelerin polarite farklarından dolayı literatürde genellikle ilaç ve hormonlar için 
ayrı yöntemler bulunmaktadır. Geliştirilen numune hazırlama yöntemi ile ilaç ve 
hormonların tek bir ölçüm yöntemi kullanılarak ölçülmesini olanaklı kılmıştır. 
Geliştirilen bu yöntemde farklı maddeler için 0,5 ila 1,1 ng/L arasında en düşük 
ölçüm limitleri elde edilmiştir.  Ultra saf su ve yüzeysel su için sırasıyla %72-119 
arasında ve %61-98 arasında geri kazanımlar elde edilmiştir.  Bazı ilaçlar, nehirlerde 
µg/L seviyesinde ölçülmüştür.  En sık tespit edilen maddeler kafein ve antibiyotikler 
iken sentetik bir hormon olan EE2 sadece 4 kez tespit edilerek en az tespit edilen 
madde olmuştur. 
İlaç ve hormonların ekolojik etkilerini belirlerken besin zincirinde farklı yerlerde 
bulunan canlılar üzerindeki farklı etkiler hakkında bilgi edinebilmek üzere çeşitli 
ekotoksikolojik araçlar kullanılmıştır.  P. subcapitata akut ekotoksik etkileri 
belilemek üzere kullanılırken D. magna hem akut hem de kronik ekotoksik etkilerin 
belirlenmesinde kullanılmıştır.  Mutajenik ve östrojenik etkileri belirlemek üzere 
sırasıyla AMES ve YES testleri kullanılmıştır. 
P. subcapitata ve D. magna ile yürütülen deneyler sonucunda ilaç ve hormonların 
yüzeysel sularda bulunan konsantrasyonlarının herhangi bir akut etki yaratması 
beklenmese de çalışılan maddelerin kronik etkilerinin ekosistem dengesini sarsıcı 
olabileceği gözlenmiştir. 
Tekil maddelerin etkilerinin gözlenmesinin yanında, bilimsel literatürde bulunan 
bilgi eksikliği nedeniyle ilaç ve hormon karışımlarının yarattığı etkiler de 
çalışılmıştır. D. magna akut ve kronik ve P. subcapitata akut ekotoksisite testlerinde 
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bütün karışımlar sinerjistik etki göstermiştir.  Ayrıca maddelerin tekil olarak etki 
göstermedikleri konsantrasyonları karıştırılmaları durumunda bu testlerde ekotoksik 
etki yaratmaktadırlar.  Bu sonuçlar, tekil maddelerin çevresel risk değerlendirme 
çalışmalarında kullanılan eşik değerlerinin yanında interaktif etkilerinin de 
belirlenmesinin daha anlamlı ve yararlı olacağını göstermektedir. 
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1. INTRODUCTION 
Definition of water pollution caused by chemical substances has long a history.  In 
1954, W. Haynes in his 6 volume book, American Chemical Industry – A History, 
wrote that “by sensible definition any by-product of a chemical operation for which 
there is no profitable use is a waste.  The most convenient, least expensive way of 
disposing of said waste – up the chimney or down the river – is the best.”  It is clear 
that once anything other than product, particularly wastes had been removed from 
industrial facilities without considering ecosystem integrity and human health 
(Hemond and Fechner-Levy, 2000). 
After the mid-60s people have become aware that some substances –for instance 
mercury derivatives (i.e., methyl mercury), DDT and PCBs- can persist in the 
environment, enter and became enriched in food chains and reach toxic levels in 
certain organisms.  Rachel Carson’s book “Silent Spring” played an important role 
on this awareness and “enlightenment” on toxic substances.  The recognition of 
toxicity has been a driving force behind the development towards better 
environmental management and stricter regulations.  Furthermore, studies triggered 
by the recognition of these effects led to realization that anthropogenic contaminants 
are present everywhere in the environment, and many of these substances are 
potentially hazardous to ecosystem. 
To emphasize the difference between identifiable chemical substances and classical 
aggregate or general parameters such as Chemical Oxygen Demand (COD), 
Biochemical Oxygen Demand (BOD) and suspended solids, the concept of “specific 
water pollutant” is being used.  The specific water pollutant was defined, by 
Organisation for Economic Co-operation and Development (OECD), as a substance 
which is mainly introduced into the environment by human activity and which, under 
given conditions, lowers the quality and value of a water resource, particularly by 
toxic and nuisance effects on human beings or aquatic life (Organisation for 
Economic Co-operation and Development., 1982). Specific water pollutants have 
also been called “trace pollutants”, “micropollutants”, and “refractory pollutants”. 
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With the development of technologically advanced analytical techniques, 
micropollutants have become a popular study area and scientists divided 
micropollutants into further classes.  For instance, the class of “Emerging 
contaminants” corresponds in most cases to unregulated contaminants, which may be 
candidates for future regulation depending on the results of research on their 
potential health effects and available monitoring data regarding their occurrence.  
Emerging pollutants include several groups of compounds such as surfactants, 
pharmaceuticals, and personal care products (PPCPs) and gasoline additives.  
Although these groups of compounds may have low half-lives in the environment, 
their continuous release may lead to accumulation in the environment and hence 
cause adverse effects.  It is difficult to predict effects of emerging contaminants since 
there are gaps on data on their occurrence and ecotoxicological effects (Petrovic et al., 
2003). The risk assessment is particularly difficult to conduct since the presence of 
these compounds in mixtures might lead to significantly different effects compared 
to their effect as a single compound. 
One possible effect of pharmaceuticals is their effect on the endocrine system of the 
exposed organisms.  The term “endocrine disrupter” gained popularity in 1992 when 
Colborn and Clement used it to address negative effects of foreign chemicals to 
endocrine system.  In 1996, The U.S. Environmental Protection Agency (USEPA) 
initiated studies to identify endocrine disrupting effects of chemicals and classify 
them.  Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) 
was founded for this purpose (Cline, 2002).  In 1998, the EDSTAC defined the 
endocrine disrupters as “an exogenous chemical substance or mixture that alters the 
structure or function(s) of the endocrine system and causes adverse effects at the 
level of the organism, its pyrogenity, populations, or subpopulations of organisms, 
based on scientific principles, data weight of evidence, and the precautionary 
principle” (EDSTAC, 1998).  Meanwhile, National Research Council (NRC) of USA 
defined the endocrine disruption of chemicals as hormonally active agents (HAA).  
HAA was defined regardless to the specific mode or mechanism of action of the 
chemical to expand the issue.  However, the term, hormonally active agents, has not 
gained popularity compared to the term, endocrine disruptors, among the public or 
scientific community (Cline, 2002).   
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As an emerging environmental issue, pharmaceutical residues in the environment 
was selected as a research priority in the European Union 5th Framework Programme 
(Ternes and Joss, 2006) and the attention of European Union to this issue continued 
during 6th Framework Programme, as well. 
The production and use of pharmaceuticals lead to a potential environmental 
exposure and also to an accumulation in certain environmental compartments.  The 
main discharge routes of human pharmaceuticals to the environment are expected to 
be through their use by patients in private households, in hospitals and the 
subsequent disposal of these pharmaceuticals through toilets.  After their use, 
pharmaceuticals are excreted as unchanged compound and/or metabolites in feces 
and urine and hence are present in wastewater (Halling-Sorensen et al., 1998). 
Wastewater treatment plants are placed downstream of sewer systems carrying 
pharmaceuticals and endocrine disrupters.  Wastewater treatment plants were usually 
designed to treat carbonaceous organic matter which can be measured as COD and 
also nutrients such as nitrogen and phosphorus.  Many pharmaceuticals are relatively 
resistant to degradation in these wastewater treatment plants and therefore, 
wastewater treatment facilities are the major sources for pharmaceuticals and 
endocrine disrupters together with industrial processes that use cleaners and plastics 
(Golet et al., 2001; Routledge and Sumpter, 1996; Snyder et al., 2003; Staples et al., 
1998; Sumpter, 1995; Ternes and Hirsch, 2000; Ternes and Joss, 2006; Ying et al., 
2002).  
Agriculture, livestock feed and fish farms have been identified as non-point sources 
of pharmaceuticals and hormones.  Estrogens and some other pharmaceuticals are 
used in fish farms to increase productivity.  Since fish farms are located in marine 
environment, pharmaceuticals and hormones that are used in these fish farms may 
easily contaminate the area.  Livestock is generally administered pharmaceuticals 
and hormones, as well, which are excreted in manure and urine.  All excreted 
pharmaceuticals and hormones can easily reach to surface water via agricultural 
runoff (Campbell et al., 2006; Kolodziej et al., 2004). 
Although it importance of and the need for occurrence studies in surface water, and  
in particular in drinking water sources is clear and well understood, the measurement 
of pharmaceuticals and hormones in surface water is quite challenging, since it 
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requires technologically advanced analytical equipment.  Moreover, the analytical 
methods have to be specific and sensitive enough to eliminate possible interferences 
in complex matrices and to quantify target compounds down to ng/L levels.  
Therefore, the ultimate analytical method should include an efficient enrichment 
technique such as solid phase extraction (SPE) and modern separation and detection 
techniques including gas chromatography coupled with mass spectrometer (GC-MS, 
GC-MS/MS) and liquid  chromatography coupled with mass spectrometer (LC-MS, 
LC-MS/MS)  
Since ecological effects of pharmaceuticals and hormones are observed at 
concentrations as low as ng/L, achievement of low analytical detection limits is 
required.  GC-MS and/or GC-MS/MS used to be the method of choice for the 
measurement of PCPP and hormones.  However, due to developments in sensitivity 
of LC-MS/MS leading to lower detection limits as well as the lack of the need for a 
derivatization step for most of the compounds, LC-MS/MS recently has started to be 
used more frequently.  Currently, the number of available analytical methods for the 
detection of pharmaceuticals and endocrine disrupting compounds is increasing but 
many still need to be developed for complex matrices (Fatta et al., 2007; Ternes and 
Joss, 2006). 
The determination of the environmental fate of a compound is a complex issue.  
Transformation and distribution processes are strongly dependent on the specific 
environmental conditions (Figure 1.1).  In general, there are two major approaches 
for environmental fate studies: Laboratory and field studies.  Field studies allow for 
the elucidation of substances behavior under realistic conditions, whereas laboratory 
experiments display only certain details of the entire scenario (Ternes et al., 2005). 
Since pharmaceuticals are designed with the intention of a biological effect, 
ecosystems, particularly organisms living in those ecosystems, might be adversely 
affected by unchanged pharmaceuticals and their metabolites discharged to the 
environment.  Researches indicate that some pharmaceuticals (e.g., ethynylestrodiol 
used in hormone replacement therapy) affect endocrine system of organisms in 
concentration levels as low as ng/L (Sumpter and Jobling, 1995).  Although higher 
pharmaceuticals are used at high concentrations for a short time, these compounds 
may also threat human health via both food web and direct exposure through 
drinking water, especially when more than one pharmaceutical is present and the 
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duration of exposure is long compared to the duration of intended use for a disease.  
Therefore, pharmaceuticals in ecosystems, in particular, in drinking water resources 
must be monitored and their fate and transport mechanisms and effects should be 
identified in order to take action against possible adverse effects of pharmaceuticals 
and to protect human health. 
 
Figure 1.1: Fate and transport of pharmaceuticals in the environment (Ternes, 1998). 
Generally, single species tests are used as bioassays in ecological impact assessment 
studies.  Single species tests are standard, informative and may provide a great deal 
of information.  However, they provide only minimal information on species’ 
interactions.  Therefore, different species at different levels of the food web should 
be selected to understand the effect mechanisms of a compound through food chain.  
Moreover, in-vitro tests also provide important data on sub-lethal and sub-chronic 
effects (Hodgson, 2004). 
Before introduction of a new medicine to the market, acute and chronic effects 
should be identified according to EU and US legislations.  Consequently, there will 
be information on effects of new medicines.  However, lack of knowledge on 
interactive effects (synergistic/antagonistic/potentiation) of pharmaceuticals still goes 
on (Santos et al., 2010).  Moreover, single ecotoxicological effects are concerned 
during environmental risk assessment studies although pharmaceuticals and 
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hormones do not present as single compounds in the environment (Jesus Garcia-
Galan et al., 2008; Kolpin et al., 2002; la Farre et al., 2008).  Some studies indicate 
that mixture effects of pharmaceuticals might be different than effects of single 
compounds (Cleuvers, 2003; DeLorenzo and Fleming, 2008; Quinn et al., 2008).  
Still these studies are far from filling knowledge gaps on mixture toxicity (Santos et 
al., 2010). 
As mentioned previously, quantitative analysis of pharmaceuticals and hormones can 
be conducted with mass spectrometers.  On the other hand, bioassays are essential 
tools for qualitative analysis for determination of the effects of pharmaceuticals and 
hormones, such as endocrine disruption.  Considering advantages and disadvantages 
of both of the systems, the use of bioassays (e.g., YES) to determine the impacts and 
the analytical techniques (e.g., LC-MS/MS) to obtain occurrence data, may provide 
different angles to make better assessments on the fate of pharmaceuticals and 
hormones (Heisterkamp et al., 2004). 
Numerous studies are conducted in developed countries reporting the occurrence of 
pharmaceuticals and hormones in surface waters.  In these studies, pharmaceuticals 
and hormones ranged from ng/L level to µg/L level (Castiglioni et al., 2005; Feitosa-
Felizzola and Chiron, 2009; Fernandez et al., 2010; Gracia-Lor et al., 2011; Gros et 
al., 2006; Kasprzyk-Hordern et al., 2008c; Kleywegt et al., 2011; Kuster et al., 2008; 
Vanderford et al., 2003; Watkinson et al., 2009). Nevertheless, more field data are 
required on the effects and fate of pharmaceuticals in the aquatic environment 
(European Environment Agency, 2010).  Besides, since concentrations of 
pharmaceuticals in wastewaters and surface water depend on the water and 
pharmaceutical usage rates, it may not be possible to estimate PPCP concentrations 
in one region based on studies conducted in other regions of the world, especially 
when the extrapolation is conducted between developed and 
developing/underdeveloped countries.   
1.1 Aim and Scope 
The aim of this study is to provide specific information on the occurrence, fate, and 
effects of pharmaceuticals and hormones in aquatic environment.  For this purpose, 
Büyükçekmece Watershed encompassing an important drinking water source of 
Istanbul was selected to conduct field studies.  14 widely used pharmaceuticals in 
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Turkey and hormones were selected according to one year-sales data obtained from 
IMS Health Turkey, in this study.   
Analytical methods for the measurement of pharmaceuticals and hormones in the 
environment need to be specific enough for the detection of target compounds among 
numberless impurities and interferences and sensitive enough to achieve low 
quantification limits.  Although several methods are available in the literature, the 
measurement method should be developed specifically for each analytical equipment.  
Therefore, in this study, a rapid and sensitive detection and quantification method 
using an ultra-performance liquid chromatograph coupled with a triple quadrupole 
mass spectrometer (UPLC-MS/MS) was developed for 14 pharmaceuticals and 
hormones.  The method consists of a SPE phase for enrichment of selected 
compounds as well as removal of interferences and a detection phase with UPLC-
MS/MS.  This method was applied in order to monitor selected compounds in 
Büyükçekmece Watershed to enable future environmental and human health risk 
assessment studies.   
During occurrence studies, samples were taken from Büyükçekmece Lake and its 5 
main tributaries.  The effect of seasons was also captured by taking samples five 
different times in a year.   
Different tools were used for the determination of ecological impacts of selected 
pharmaceuticals and hormones to cover different effects and understand responses of 
different species at different levels of the food web.  P. subcapitata was used for the 
determination of acute effects whereas D. magna was used for the determination of 
both acute and chronic effects.  Mutagenic and endocrine disruptive effects were 
determined with AMES and YES test, respectively.  Moreover, since the effects of 
compounds in mixtures are not necessarily the same as the effects of single 
compounds, effects of selected compounds were also determined in mixture which 
are formed based on occurrence data. 
1.2 Main Findings 
A rapid and sensitive analytical measurement method was developed for measuring 
pharmaceuticals and hormones in surface water.  Since polarities of pharmaceuticals 
and hormones are different, available analytical methods tend to measure them 
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separately.  The developed method is one of the few in the literature for multi-residue 
analysis of both pharmaceutical and hormones.   
This is the first study in Turkey and one of the few studies in developing countries 
reporting the occurrence of pharmaceuticals and hormones in surface water.  
Therefore, this study provides valuable information for future environmental and 
human health risk assessment studies.  Moreover, ecotoxicological data on mixture 
effects provide valuable information to understand interactive effects of 
pharmaceutical and hormones on which there is a huge knowledge gap worldwide. 
Since occurrence data are the results of a field study conducted in a watershed used 
for the supply of drinking water in Istanbul, they provide information for decision 
makers to take action against possible adverse effects of studied compounds.  
Moreover, the data will be helpful for the implementation of Water Framework 
Directive of European Commission.   
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2. LITERATURE REVIEW 
2.1 Consumption of Pharmaceuticals and Hormones 
Generally, there is a positive correlation between the most frequently used classes of 
pharmaceutical and their detection in the aquatic environment.  Many of the top sold 
pharmaceuticals are specific beta blockers, lipid regulators, antidiabetic, antianginal 
drugs, as well as analgesics and antibiotics (Jones et al., 2001).  It is estimated that 
100,000 tons per year of pharmaceuticals are consumed in global scale 
corresponding approximately 15 g/cap.year (Kümmerer, 2004).  Personal 
consumption may increase to 150 g/cap.year in developed countries (Ternes and Joss, 
2006).  Estimation of consumption of pharmaceuticals is a controversial issue.  There 
are different methods to collect data.  It may rely on prescriptions or sales.  It is well 
known that non-prescribed sales of pharmaceuticals at least ten times higher than 
prescribed sales (Kümmerer, 2004).  Therefore, consumption of pharmaceuticals and 
hormones must be estimated according to sales data.  However, it is difficult to 
achieve sales data of pharmaceuticals in particular developing countries such as 
Turkey. 
Trends and habits of consumption of pharmaceuticals and hormones may differ from 
country to country and over time.  In general, non-steroidal anti-inflammatory drugs 
(NSAID) and antibiotics are mostly consumed pharmaceuticals all over the world.  
However, it is known that consumption of pharmaceuticals may differ from country 
to country even said pharmaceuticals belong to the same therapeutic group.  For 
instance, while ibuprofen the most consumed NSAID in Sweden it is diclofenac for 
Austria (Ternes and Joss, 2006).  Moreover, antibiotics are consumed more in 
developing countries than in developed countries.  Furthermore, antibiotics and 
analgesics are consumed more in winter.  
From now on there is only one study conducted in Turkey that predicts 
environmental concentrations of only antibiotics using PEC/PNEC model 
(Turkdogan and Yetilmezsoy, 2009).  
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2.2 Occurrence of Pharmaceuticals and Hormones in Aquatic Environment 
There are different routes that pharmaceuticals and hormones enter to the 
environment.  Sewer systems are the main collection structures of pharmaceuticals 
and hormones since after usage or flushed down from toilets in households or 
hospitals, they enter to sewer systems and eventually end up in a wastewater 
treatment plant.  In many research, it is observed that many pharmaceuticals are 
resistant towards degradation during wastewater treatment and they are discharged to 
environment via treated wastewater from wastewater treatment plants which may be 
considered as main sources of pharmaceuticals (Golet et al., 2001; Routledge and 
Sumpter, 1996; Snyder et al., 2003; Staples et al., 1998; Sumpter and Jobling, 1995; 
Ternes and Hirsch, 2000; Ternes and Joss, 2006; Ying et al., 2002).  There is also 
possibility that discharge of untreated wastewater to surface water in developing 
countries such as Turkey.  There are other minor routes of pharmaceuticals and 
hormones to the environment as: release of private septic/leach fields, reinjection to 
aquifers or reuse for irrigation of treated wastewater, transfer of biosolids to land, 
release from agriculture, manure from medicated domestic animals, direct release to 
open water via washing/bathing/swimming, discharge of controlled industrial 
wastewater, disposal from illegal drug labs and illicit drug usage, disposal to landfills 
via domestic refuse and medical waste, leaching from landfills and cemeteries, 
release to open water from aquaculture,. Moreover, ultimate fate and transport 
mechanisms of pharmaceuticals and hormones in the environment may cause further 
release (Petrović and Barceló, 2007).  Therefore, pharmaceuticals may accumulate 
certain points in the environment and living organisms after use and disposal 
(Halling-Sorensen et al., 1998). 
Approximately 10-100 µg/day estrogens are removed from a woman’s body in 
normal menstrual cycle.  This amount may increase to 30 mg/day during pregnancy.  
Most of the estrogenic activity of wastewater and surface water is caused by E2 and 
EE2 in ng/L concentrations (Snyder et al., 2001).  Although predicted no effect 
concentration (PNEC) of EE2 was estimated as 0.35 ng/L (Skotnicka-Pitak et al., 
2008), it is observed that 0.1 ng/L EE2 had been triggered feminization of fish 
(Purdom et al., 1994).  Nevertheless, other natural hormones, E1 and E3, go into 
wastewater via urine and are expected to have endocrine disruptive effect since they 
have similar metabolites with E2 and EE2. 
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Mass spectrometric methods are used to determine occurrence and fate of 
pharmaceuticals and hormones in the environment.  Although these methods do not 
provide information on estrogenic activity of target compounds, their sensitivity and 
selectivity make them essential for quantification of compounds as low as ng/L 
levels (Campbell et al., 2006). 
Mass spectrometer (MS) is used as hyphenated technique to both of the gas 
chromatographer (GC) and liquid chromatographer (LC).  MS is not only very 
sensitive and selective but also provides information about molecular structure of 
measured compounds.  The only available method to quantify organic materials in 
complex environmental matrices is MS.  Before, GC-MS was generally used to 
quantify organic compounds thanks to its very high chromatographic resolution.  
However, GC had actually been designed to quantify volatile and half volatile 
organic compounds.  After development of electrospray ionization (ESI), 
atmospheric pressure chemical ionization (APCI), and atmospheric pressure 
photoionization (APPI) in 90s, LC-MS started to be used more commonly.  High 
resolution or tandem MS (HRMS or MS/MS) provide detailed structural information 
and in most cases are necessary to quantify pharmaceuticals and hormones at low 
concentrations since they make possible identification of compounds having same 
molecular weight even though they do not chromatographically separated (Fatta et al., 
2007; Ternes and Joss, 2006).   
Analytical techniques used for measurement of rather more polar and low molecular 
weighted pharmaceuticals and hormones in environmental waters must be sensitive 
and selective enough to make quantification possible down to ng/L levels.  Therefore, 
technologically advanced hyphenated analytical techniques (e.g., GC-MS/MS and 
LC-MS/MS) must be used in multi-residue analysis of pharmaceuticals and 
hormones in environmental waters.  One disadvantage of these kinds of analytical 
techniques is need of long time to achieve reliable determination method.  Although 
there are some analytical measurement methods for quantification of pharmaceuticals 
and hormones in the literature, there is still need for development of new methods in 
particular for complex water matrices (Ternes and Joss, 2006). 
Although GC methods are very sensitive and selective, their need for derivatization 
of polar and charged compounds diverts the attention to LC methods (Ternes and 
Joss, 2006). 
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Ternes (2001) directly compared GC-MS and LC-electrospray ionization (ESI)-
MS/MS, and showed that only LC-(ESI)-MS/MS allows the analysis of extreme 
polar compounds (e.g., b-blockers, atenolol and sotalol) due to an incomplete 
derivatization of the functional groups.  Further, the relative standard deviation using 
LC-(ESI)-MS/MS was found to be lower.  However, when analyzing highly 
contaminated samples, such as sewage, suppression of electrospray ionization is 
likely to occur, so, to guarantee accurate, reproducible data, either an efficient clean-
up step has to be included in sample preparation or an appropriate surrogate standard 
has to be spiked prior to enrichment by solid phase extraction (SPE). 
Farré et al. (2001) compared LC-(ESI)-MS and GC-MS (after derivatization with 
BF3-MeOH) for monitoring some acidic and very polar analgesics (salicylic acid, 
ketoprofen, naproxen, diclofenac, ibuprofen, and gemfibrozil) in surface water and 
wastewater.  The results showed a good correlation between methods, except for 
gemfibrozil, for which derivatization was not completely achieved in some samples.  
In general, the limits of detection (LODs) achieved so far with LC-MS/MS methods 
are slightly higher than those obtained with GC-MS methods; however, LC-MS 
methodology showed advantages in terms of versatility and sample preparation being 
less complicated (i.e. derivatization is not needed) (Diaz-Cruz and Barcelo, 2005; 
Farré et al., 2001).  Since there are various advantages of LC-MS/MS methods 
against GC-MS/MS methods and the determination and measurement of 
concentrations of most of the pharmaceuticals are possible with LC-MS/MS (Figure 
2.1), LC-MS/MS became more popular in scientific community for measurement of 
pharmaceuticals and hormones in environmental waters.   
During analysis of pharmaceuticals and hormones, an enrichment method should be 
used to reach ng/L levels.  Solid phase extraction (SPE) is the most widely used 
enrichment technique (Ternes and Joss, 2006).  Previously, C18 was used as solid 
phase for enrichment of pharmaceuticals and hormones.  Then other SPE cartridges 
having engineered adsorbents such as EnciCarb, LiChrolut, Isolut ENV+, Oasis HLB, 
and Oasis MCX started to be used.  Recently, Oasis HLB is cartridge of choice in 
most of the studies thanks to its hydrophilic and lipophilic balanced adsorbent 
increasing recoveries and adsorbing nearly all of the pharmaceuticals and hormones.   
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Figure 2.1: Analytical methods applied for the most common pharmaceuticals in 
water and wastewater (Fatta et al., 2007). 
Today most of the studies in the literature are on antibiotics, NSAIDs, and blood 
lipid lowering agents due to their high prescription rates.  Studies on sex hormones 
and β-blockers come next (Santos et al., 2010).  Occurrence studies generally focus 
on pharmaceuticals and hormones in surface water and wastewater.  There are small 
amount of studies on pharmaceuticals and hormones in groundwater and sediment.   
Antibiotics generally measured at low ng/L concentrations in surface water (Table 
2.1).   
 
 
LC-MS or LC-MS/MS 
17α –Ethinylestradiol, 17β –Estradiol, Acetyl-sulfamethoxazole, Amidotrizoic 
acid, Aminopyrine, Amoxycillin, Anhydro-erythromycin, Atenolol, Betaxolol, 
Bisoprolol, Chloramphenicol, Chlortetracyline, Ciprofloxacin, Clarithromycin, 
Clenbuterol, Cloxacillin, Cyclophosphamide, Dapsone, Demethyl diazepam, 
Dextropropoxyphene, Dicloxacillin, Doxycycline, Oleandomycin, 
Sulfamethazine, Estrone, Simvastatin, Sulfapyridine, Hydrochlorothiazide 
Sotalol, Sulfasalazine, Iopamidol, Omeprazole, Sulfathiazine, Lofepramine, 
Oxacillin, Tamoxifen, Metronidazole, Oxytetracycline, Terbutaline, 
Ofloxacin, Penicillin G, Tetracycline, Enalapril, Penicillin V, Tilmicosin, 
Furazolidone, Pindolol, Trimethoprim, Ifosfamide, Piroxicam, Tylosin, 
Ketorolac, Ranitidine, Virginiamycin, Methicillin, Ronidazole, Nafcillin, 
Spiramycin, Erythromycin, Sulfacetamide, Furosemide, Sulfadiazine, 
Iomeprol, Sulfadimethoxine, Lincomycin, Sulfadimidine, Methotrexate, 
Sulfaguanidine, Norfloxacin 
Carbamazepine 
Diazepam 
Ibuprofen 
Paracetamol 
Phenazone 
GC-MS or GC-MS/MS 
without derivatization 
Aspirin 
Codeine 
Cyclophosphamide 
Galaxolide 
Pentoxyfylline 
Tonalide 
Triclosan 
GC-MS or GC-MS/MS 
after derivatization 
Aspirin 
Etofibrate 
Etofyllinclofibrat 
Flurbiprofen 
Ketoprofen 
Nadolol 
Tolfenamic acid
Bezafibrate, Clofibrate, Diclofenac, 
Fenofibrate, Fenoprofen, Gemfibrozil, 
Indomethacine, Iopromide, Mefenamic 
acid, Metoprolol, Naproxen, Propranolol, 
Propyphenazone, Roxithromycin, 
Salbutamol, Sulfamethoxazole,  
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Table 2.1: Literature survey on concentrations of studied antibiotics in surface water. 
Compound Sample Country Analytical Procedure LOD (ng/L) 
Measured 
Concentration (ng/L) Reference 
Amoxicillin Surface water UK LC-MS/MS 10 ND-552 (Kasprzyk-Hordern et al., 2008c) 
Ciprofloxacin Surface water USA LC-MS 20 20 (Kolpin et al., 2002) 
Po River  Italy LC-MS/MS 0.3 ND-26.15 (Calamari et al., 2003) 
Erythromycin 
Lambro River Italy LC-MS/MS 0.3 1.4-15.90 (Calamari et al., 2003) 
Mankyung River South Korea LC-MS/MS 1 ND-137 (Kim et al., 2009) 
Victoria Harbour 
Seawater 
Pearl River Water 
China LC-MS 
2 (LOQ 
seawater) 
5(LOQ river 
water) 
5.1-6.1 (Xu et al., 2007) 
Sulfamethoxazole
Surface water USA LC-MS 50 150 (Kolpin et al., 2002) 
Drinking water USA LC-MS/MS 0.25 0.32 (Benotti et al., 2009) 
Alzette River Luxembourg LC-MS/MS 0.3 1-22 (Pailler et al., 2009) 
Mess River Luxembourg LC-MS/MS 0.3 0.3-5 (Pailler et al., 2009) 
Surface water UK LC-MS/MS 0.5 ND-351 (Kasprzyk-Hordern et al., 2008c) 
Surface water South Korea LC-MS/MS 1 1.7-36 (Kim et al., 2007a) 
Han River South Korea LC-MS 5 ND-82 (Choi et al., 2008) 
Rio Grande River USA LC-MS 12 ND-300 (Brown et al., 2006) 
Tevere River Italy LC-MS 9 402 (Perret et al., 2006) 
Drinking Water Italy LC-MS 9 13-80 (Perret et al., 2006) 
Pearl River China LC-MS 1 (LOQ) 37-134 (Xu et al., 2007) 
LOD: Limit of Detection 
LOQ: Limit of Quantification 
ND: Not Detected 
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All of the studies on occurrence of studied antibiotics in surface water were 
conducted in developed countries.  There is not any concentration pattern for each 
antibiotic.  Concentrations are ranged from <0.3 to 550 ng/L.   
There are more studies on occurrence of antibiotics in wastewater.  Obviously 
concentrations in wastewater were measured higher than concentrations in surface 
water.  Ciprofloxacin was measure as high as 1000 ng/L and 300 ng/L in influent and 
effluent of wastewater treatment plant, respectively (Brown et al., 2006; Lindberg et 
al., 2005; Seifrtova et al., 2008).  Moreover, in ciprofloxacin concentration was once 
reported as 11 µg/L in hospital wastewater (Seifrtova et al., 2008).  Although similar 
concentrations were reported for erythromycin in influent between 226 and 1537 
ng/L, effluent concentrations were measured higher than ciprofloxacin between 361 
and 811 ng/L (Lin et al., 2009).  One of the most studied antibiotics, 
sulfamethoxazole, was in different ranges in different countries.  For instance, while 
concentration in influent between 179 and 1760 ng/L and in effluent between 47 and 
964 ng/l in Taiwan (Lin et al., 2009), in Luxemburg, the concentration in influent 
was reported between 13 and 155 ng/L and in effluent between 4 and 39 ng/L (Pailler 
et al., 2009).   
β-blockers are the least studied compounds among the compounds in this study 
(Table 2.2). 
There is a big difference of highest reported concentration of atenolol in surface 
water between South Korea and other countries.   
Atenolol was measured as high as 2883 ng/L, 1168 ng/L, 800 ng/L in the influent of 
wastewater treatment plant in Taiwan, Italy, and Finland, respectively (Castiglioni et 
al., 2005; Lin et al., 2009; Vieno et al., 2006).  440 ng/L effluent concentration in 
Finland and 681 ng/L effluent concentration in Taiwan indicate low removal 
efficiency of atenolol.  In one case atenolol was reported 122 µg/L in hospital 
wastewater in Spain (Gomez et al., 2006). 
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Table 2.2: Literature survey on concentrations of studied β-blockers in surface water. 
Compound Sample Country Analytical Procedure 
LOD 
(ng/L)
Measured 
Concentration 
(ng/L) 
Reference 
Atenolol Vantaa 
River and 
Luhtajoki 
River 
Finland LC-MS/MS 11.8 11.8-25 
(Vieno et 
al., 2006) 
Hoje 
River Sweden 
LC-
MS/MS NA 10-60 
(Bendz et 
al., 2005) 
Po River 
and 
Lambro 
River 
Italy LC-MS/MS 0.3 3.44-39.43 
(Calamari 
et al., 
2003) 
Drinking 
water USA 
LC-
MS/MS 0.25 0.47 
(Benotti 
et al., 
2009) 
Mankyung 
River 
South 
Korea 
LC-
MS/MS 30 ND-690 
(Kim et 
al., 2009) 
Propranolol Hoje 
River Sweden 
LC-
MS/MS NA ND-10 
(Bendz et 
al., 2005) 
Tyne 
River UK 
LC-
MS/MS 10 35-107 
(Roberts 
and 
Thomas, 
2006) 
Mankyung 
River 
South 
Korea 
LC-
MS/MS 10 ND-40.1 
(Kim et 
al., 2009) 
Surface 
water UK 
LC-
MS/MS 10 ND-37 
(Hilton 
and 
Thomas, 
2003) 
LOD: Limit of Detection 
LOQ: Limit of Quantification 
ND: Not Detected 
NA: Not reported 
Since propranolol’s excretion rate as unchanged compound is below 1%, 
concentrations of propranolol rather low.  Even in wastewater, propranolol was 
measured 50 ng/L, 119 ng/L, and 180 ng/L in Sweden and UK (Bendz et al., 2005; 
Hilton and Thomas, 2003; Roberts and Thomas, 2006). 
Estrogens were measured in low ng/L concentrations (Table 2.3). 
 17 
 
Table 2.3: Literature survey on concentrations of studied hormones in surface water. 
Compound Sample Country Analytical Procedure 
LOD 
(ng/L) 
Measured 
Concentration 
(ng/L) 
Reference 
E1 Alzette River Luxembourg LC-MS/MS 0.3 0.3-6 (Pailler et al., 2009) 
Mess River Luxembourg LC-MS/MS 0.3 0.3-27 (Pailler et al., 2009) 
Tamagawa and Kasumigura 
Rivers Japan LC-MS/MS 0.1 3.4-6.6 (Isobe et al., 2003) 
Surface water Germany LC-MS/MS 0.1 0.16 (Zuehlke et al., 2005) 
Tibre River Italy LC-MS/MS 0.1 5-12 (Lagana et al., 2004) 
Surface water France LC-MS/MS 0.02 0.3 (Vulliet et al., 2008) 
E2 Alzette River Luxembourg LC-MS/MS 1 1-35 (Pailler et al., 2009) 
Mess River Luxembourg LC-MS/MS 1 1-6 (Pailler et al., 2009) 
Tamagawa and Kasumigura 
Rivers Japan LC-MS/MS 0.3 0.6-1.0 (Isobe et al., 2003) 
Surface water Germany LC-MS/MS 0.2 ND (Zuehlke et al., 2005) 
Tibre River Italy LC-MS/MS 0.2 2-6 (Lagana et al., 2004) 
E3 Surface water South Korea LC-MS/MS 5 ND (Kim et al., 2007a) 
Tibre River Italy LC-MS/MS 0.1 2-5 (Lagana et al., 2004) 
EE2 Alzette River Luxembourg LC-MS/MS 2 ND (Pailler et al., 2009) 
Mess River Luxembourg LC-MS/MS 2 ND (Pailler et al., 2009) 
Surface water South Korea LC-MS/MS 1 ND (Kim et al., 2007a) 
Surface water Germany LC-MS/MS 0.2 ND (Zuehlke et al., 2005) 
Tibre River Italy LC-MS/MS 0.4 ND-1 (Lagana et al., 2004) 
LOD: Limit of Detection 
LOQ: Limit of Quantification 
ND: Not Detected 
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Estrogen hormones were reported at the lowest concentrations among studied 
compounds in the literature.   
Even though low concentrations of E1 in surface water 197 ng/L and 110 ng/L in 
influent and effluent of wastewater treatment plant in Japan were reported (Nakada et 
al., 2006).  High concentration of E1 in influent of wastewater treatment plant was 
also reported in Germany as 188 ng/L (Zuehlke et al., 2005). 
Concentrations of E2 in influent of wastewater treatment plant was similar to surface 
water in in Japan, Italy and Germany with concentration range 10-31 ng/L (Lagana et 
al., 2004; Nakada et al., 2006; Zuehlke et al., 2005).  Higher concentration range was 
reported in Luxemburg for E2 in influent as 1-102 ng/L (Pailler et al., 2009).  In 
effluent much lower concentrations (0.49-12.4 ng/L for Japan, 0.8 ng/L for Germany, 
and 2-6 ng/L for Italy) were observed.   
Similar effluent concentrations for E3 were reported in Japan (0.31-0.84 ng/L), South 
Korea (8.9-25 ng/L), and Italy (<0.5-1 ng/L) (Kim et al., 2007a; Lagana et al., 2004; 
Nakada et al., 2006). 
Below detection limit concentration was generally reported for EE2 in effluents 
except in South Korea (1.3 ng/L) and Germany (1.7 ng/L). 
After antibiotics, NSAID is the most studied and most detected pharmaceutical group 
(Santos et al., 2010).  Therefore, there are more occurrence data reported (Table 2.4).  
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Table 2.4: Literature survey on concentrations of studied NSAIDs in surface water. 
Compound Sample Country Analytical Procedure 
LOD 
(ng/L) 
Measured Concentration 
(ng/L) Reference 
Diclofenac Hoje River Sweden GC-MS NA 10-120 (Bendz et al., 2005) 
Paraiba do Sul River Brazil GC-MS 10 20-60 (Stumpf et al., 1999) 
River water Germany LC-MS/MS 7 26-72 (Hernando et al., 2006) 
Elbe River and Alster 
Lake Germany GC-MS 0.08 42-67 (Weigel et al., 2004) 
Alzette River Luxembourg LC-MS/MS 0.3 0.3-55 (Pailler et al., 2009) 
Mess River Luxembourg LC-MS/MS 0.3 0.3-19 (Pailler et al., 2009) 
Surface water South Korea LC-MS/MS 1 8.8-127 (Kim et al., 2007a) 
Surface water UK LC-MS/MS 20 350-460 (Hilton and Thomas, 2003) 
Ibuprofen Somes River Romania GC-MS 30 ND-115 (Moldovan, 2006) 
Hoje River Sweden GC-MS NA 10-220 (Bendz et al., 2005) 
Po River  Italy LC-MS/MS 4.2 ND-9.76 (Calamari et al., 2003) 
Lambro River Italy LC-MS/MS 4.2 78.5 (Calamari et al., 2003) 
Tyne River UK LC-MS/MS 20 144-2370 (Roberts and Thomas, 2006) 
River water Germany LC-MS/MS 12 60-152 (Hernando et al., 2006) 
Elbe River Germany GC-MS 0.05 8.7-32 (Weigel et al., 2004) 
Alster Lake Germany GC-MS 0.05 4.9 (Weigel et al., 2004) 
Alzette River Luxembourg LC-MS/MS 0.3 10-295 (Pailler et al., 2009) 
Mess River Luxembourg LC-MS/MS 0.3 9-2383 (Pailler et al., 2009) 
Surface water South Korea LC-MS/MS 1 11-38 (Kim et al., 2007a) 
Mankyung River South Korea LC-MS/MS 5 ND-414 (Kim et al., 2009) 
Surface water UK LC-MS/MS 20 ND (Hilton and Thomas, 2003) 
Naproxen 
Hoje River Sweden GC-MS NA 90-250 (Bendz et al., 2005) 
Paraiba do Sul River Brazil GC-MS 10 ND-50 (Stumpf et al., 1999) 
River water Germany LC-MS/MS 26 70 (Hernando et al., 2006) 
Pearl River China GC-MS 1.3 ND-118 (Zhao et al., 2009) 
Surface water South Korea LC-MS/MS 1 1.8-18 (Kim et al., 2007a) 
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Diclofenac was reported as high as 3600 ng/L in influent of wastewater treatment 
plant in Spain (Gomez et al., 2007).  Similar concentrations were reported in 
Switzerland, Canada, and UK (Lee et al., 2005; Martinez Bueno et al., 2009; Roberts 
and Thomas, 2006; Tauxe-Wuersch et al., 2005).  High concetrations of diclofenac 
was also reported in effluent in Spain (140-2200 ng/L and 890-1440 ng/L), 
Switzerland (1300-2400 ng/L), Canada (32-448 ng/L), UK (261-598 ng/L and 350-
460 ng/L), and Belgium (32-1420 ng/L) (Gomez et al., 2006; Hernando et al., 2006; 
Hilton and Thomas, 2003; Martinez Bueno et al., 2009; Roberts and Thomas, 2006; 
Tauxe-Wuersch et al., 2005; Verenitch et al., 2006).  There are also studies reporting 
low concentrations (8-250 ng/L) of diclofenac in influent and effluent (Bendz et al., 
2005; Hernando et al., 2006; Kim et al., 2007a; Koutsouba et al., 2003; Pailler et al., 
2009; Stumpf et al., 1999; Zhao et al., 2009). 
Ibuprofen is the most studied NSAID and highest concentrations among 
pharmaceuticals were reported for ibuprofen.  For instance, 34000-168000 ng/L and 
240-28000 ng/L of ibuprofen were measured in Spain in influent and effluent, 
respectively (Gomez et al., 2007).  UK is another country that ibuprofen 
concentrations were observed at extremely high concentrations in influent (7741-
33764 ng/L) and effluent (1979-2370 ng/L) of wastewater treatment plants (Roberts 
and Thomas, 2006).  High concentrations were also observed in Switzerland (1750-
400 ng/L in influent and 100-1200 ng/L in effluent), Canada (4100-10210 ng/L in 
influent and 2235-6718 ng/L in effluent), Romania (110-2170 ng/L in effluent), 
Belgium (18-1860 ng/L in effluent), Taiwan (711-17933 ng/L in influent and 313-
3777 ng/L in effluent), and UK (1700-3800 ng/L in effluent) (Hernando et al., 2006; 
Lin and Tsai, 2009; Lin et al., 2009; Moldovan, 2006; Tauxe-Wuersch et al., 2005; 
Verenitch et al., 2006). 
Naproxen is the least studied compound among NSAIDs.  Concentrations of 
naproxen in wastewater and treated wastewater are similar to concentrations of 
diclofenac.  Naproxen concentrations was reported as 1730-6030 ng/L in influent and 
360-2540 ng/L in effluent in Canada (Lee et al., 2005), 271-7962 ng/L in effluent in 
another study in Canada (Verenitch et al., 2006), 3650 ng/L in influent and 250 ng/L 
in effluent in Sweden (Bendz et al., 2005), 109-455 ng/L in effluent in Spain 
(Hernando et al., 2006), 31 ng/L in effluent in USA (Thomas and Foster, 2004), 625 
ng/L in effluent in Belgium (Hernando et al., 2006), 38-320 ng/L in influent and 12-
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139 ng/L in effluent in Japan (Nakada et al., 2006), 20-483 ng/L in effluent in South 
Korea (Kim et al., 2007a). 
Concentration differences of pharmaceuticals and hormones among the countries and 
even in the countries indicate that it is not possible to predict concentrations of 
pharmaceuticals and hormones in regional basis. 
2.3 Fate and Behavior of Pharmaceuticals and Hormones in Aquatic 
Environment 
Residues of various pharmaceuticals are present in the low μg/L range in wastewater 
treatment plant effluents.  Discharge of the wastewater treatment plan effluent into 
receiving waters leads to a dilution of the pharmaceutical residues which occur up to 
the high ng/L range in contaminated surface water.  Once introduced into the surface 
waters, pharmaceuticals may undergo biodegradation, most likely due to co-
metabolic processes.  For some pharmaceuticals, i.e. diclofenac, photo induced 
degradation may occur from natural solar radiation (Andreozzi et al., 2003).  
Additionally, depending on the lipophilicity and specific sorption properties of a 
particular pharmaceutical, distribution between aqueous solution and sediment and 
suspended matter occurs (Schwarzenbach et al., 2003).  Sorption to particular matter, 
or formation of bound residues might result in a change in the transformation 
behavior.  However, the extent of pharmaceutical sorption to particulate matter is 
hardly known.  Therefore, further research is still needed on the fate and behavior of 
pharmaceuticals and hormones in the aquatic environment (Santos et al., 2010).  
After use or disposal of pharmaceuticals and hormones they are introduced to the 
environment mainly through wastewater treatment plants or from agricultural lands 
via runoff.  Since most of the pharmaceuticals and hormones are resistant to 
degradation they reach to surface water and eventually groundwater (Daughton and 
Ternes, 1999; Halling-Sorensen et al., 1998; Heberer, 2002).  However, there are 
some findings indicating they may undergo some degradation processes such as 
photolysis which strongly depends on intensity of solar irradiation, latitude, season of 
the year and presence of photosensitizes (e.g. nitrates, humic acids) (Bartels and von 
Tuempling, 2007; Boreen et al., 2003; Santos et al., 2010). 
Since pharmaceuticals and hormones are highly polar and not volatile, they are easily 
transported in the aquatic environment and even through food chain (Crane et al., 
 22 
 
2006; Daughton and Ternes, 1999).  In developed countries, wastewater treatment 
plants are considered main sources of pharmaceuticals and hormones.  However, 
there are some regions even countries this is not valid since wastewater collection 
and treatment cannot be established scientifically.  Moreover, wastewater treatment 
plants’ removal efficiency of pharmaceuticals and hormones may be dramatically 
different from plant to plant (Roberts and Thomas, 2006; Santos et al., 2010; Ternes, 
1998). 
Similar to other compounds of anthropogenic origin, the fate of the pharmaceuticals 
residues during sewage treatment can follow one or a combination of three types of 
behavior: a) (bio)degradation (mineralization), b) sorption of the residues onto  
sewage sludge or c) no elimination.  The latter results in their presence in treated 
wastewater (Halling-Sorensen et al. , 1998). 
Since pharmaceuticals and hormones have moderate to high log Koc values, they 
either create organic complexes or be adsorbed to the sediment.  After adsorption to 
the sediment, pharmaceuticals and hormones are become more available to be 
exposed to organisms, transformation, and degradation.  If they are not adsorbed, 
they become more mobile and move in water column.  Therefore, human and other 
organisms are open to both direct exposure and exposure via food web (Campbell et 
al., 2006). 
The solubility values would suggest that most endocrine disrupters would generally 
not remain in solution.  However, endocrine disrupters have been identified in water 
samples collected throughout the world (Ferguson et al., 2001; Petrovic et al., 2004; 
Rice et al., 2003; Thurman et al., 1992; Ying et al., 2002).  In some cases endocrine 
disrupters have been found in groundwater and drinking water samples suggesting 
some type of soluble transport (López-Roldán et al., 2004; Petrovic et al., 2003).  
“Possible hypotheses for these observations include (1) more soluble precursors or 
metabolites, (2) colloid facilitated transport, (3) enhanced solubility through elevated 
pH (many endocrine disrupters have a pKa around 10), and (4) the formation of 
micelles.  The formation of micelles can greatly enhance the stability of a compound, 
as well as facilitate the stability of other low solubility endocrine disrupters in 
solution” (Campbell et al., 2006). 
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2.3.1 Effects of pharmaceuticals and hormones to aquatic organisms 
Adverse effects of chemicals to living organisms were determined with information 
obtained from toxicity experiments.  Toxicity of a chemical depends on 
concentration and exposure time.  During toxicology tests living organisms are used.  
Therefore, toxicology tests are also called bioassays.  To obtain reproducible results, 
toxicity tests are conducted under standardized conditions.  These conditions are 
designed to establish that only variable is tested chemical.  After standardized tests, 
data can be presented as “concentration-response” or “dose-response” curves after 
proper statistical treatment.  These curves represent degrees of responses to definite 
concentration or dose of the chemical (Rand, 1995).  Bioassays, particularly chronic 
toxicity tests, are essential tools for risk analysts to predict possible environmental 
hazards (Ostrander, 1996). 
There are different types of toxicity tests.  It is possible to divide the toxicity tests 
into two main groups as in vivo tests and in vitro tests.  In vivo tests are conducted 
using whole organisms to find out acute, chronic, and sub-chronic effects of 
chemicals.  In vivo tests are conducted using isolated cell systems to find out 
genotoxicity or cell transformation (Hodgson, 2004). 
In order to extrapolate meaningful, relevant, and ecologically significant results from 
aquatic toxicity tests appropriate organisms should be used.  Several criteria that 
should be considered in selecting organisms for toxicity testing are proposed by 
Rand (1995): 
1. Because sensitivities vary among species, a group of species representing a 
broad range of sensitivities should be used whenever possible. 
2. Widely available and abundant species should be considered. 
3. Whenever possible, species should be studied that are indigenous to or 
representative of the ecosystem that may receive the impact. 
4. Recreationally, commercially, or ecologically important species should be 
selected. 
5. Species should be amenable to routine maintenance in the laboratory and 
techniques should be available for culturing and rearing them in the 
laboratory so as to facilitate both acute and chronic tests. 
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6. If there is adequate background information on a species (i.e. physiology, 
genetics and behavior), the data from a test may be more easily interpreted. 
Although mass measurements are necessary for fate and transport studies of 
pharmaceuticals and hormones, they do not provide information on ecological effects 
(e.g., ecotoxicological, endocrine disruptive) of these chemicals (Campbell et al., 
2006). 
Endocrine disruption is another adverse effect of chemicals to living organisms.  
Detection of estrogenicity occurs by a number of mechanisms, including cell 
proliferation, ligand binding, vitellogenin induction, luciferase induction, or antigen–
antibody interaction.  These tests can be divided into three groups as whole organism 
assays, cellular bioassays, and non-cellular assays (Campbell et al., 2006). 
Measuring endocrine disruption using whole organism assays relies on observation 
of change in population dynamics, reproduction deficiencies, gonad development, 
and vitellogenin synthesis in higher organisms such as amphibians, avian, and fish.  
Cellular estrogenicity bioassays can be summarized as YES, ER-CALUX, and E-
SCREN.  The most used non-cellular estrogenicity bioassays are the enzyme-linked 
immunosorbent assays (ELISA) and the enzyme-linked receptor assay (ELRA).  
Among estrogenicity bioassays ER-CALUX has the lowest detection limit with 0.14 
ng/L.  E-SCREEN and YES tests come after ER-CALUX with 0.27 ng/L and 0.3 
ng/L detection limits, respectively (Campbell et al., 2006). 
Pharmaceuticals are principally designed to persist in the body after administration.  
That might be the reason that many pharmaceuticals such as the lipid regulator 
clofibric acid, the antiepileptic carbamazepine or the contrast medium diatrizoate are 
relatively resistant towards degradation under environmental conditions and pass 
through the STP without major elimination (Ternes, 1998; Ternes and Hirsch, 2000). 
Approximately 70% of the ecotoxicological studies of pharmaceuticals and 
hormones in the literature are on acute toxicity of them.  Only 30 % of those studies 
deal with chronic effects.  Growth inhibition, reproduction, immobilization, survival 
are the most used endpoints (Santos et al., 2010).   
Since antibiotics are designed to cure diseases via adversely affecting organisms, 
they are intersection of environmental contamination and human health protection.  
The main problem caused by antibiotics is development of antibiotic resistance of 
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microorganisms and consequently losing effectiveness of antibiotics (Crane et al., 
2006; Sanderson et al., 2004).  They also have deleterious effects to higher 
organisms (Table 2.5).   
Table 2.5: Literature survey on ecotoxicological effects of studied antibiotics. 
Compound Species Toxicological Endpoint Ecotoxicity Data Reference 
Amoxicillin M. 
aeruginosa 
EC50 (72h growth 
inhibition) 3.7 µg/L 
(Lutzhoft et 
al., 1999) 
P. 
subcapitata 
NOEC (72h growth 
inhibition 250 mg/L 
(Lutzhoft et 
al., 1999) 
S. 
leopoliensis 
EC50 (growth 
inhibition) 2.2 µg/L 
(Andreozzi et 
al., 2004) 
S. 
leopoliensis 
NOEC (growth 
inhibition) 0.78 µg/L 
(Andreozzi et 
al., 2004) 
V. fischeri 
EC50 (15 min, 
inhibition in 
luminescence) 
3597 mg/L (Park and Choi, 2008) 
Erythromycin D. magna EC50 (24h immobilization) 22.45 mg/L 
(Isidori et al., 
2005b) 
C. dubia EC50 (24h immobilization) 10.23 mg/L 
(Isidori et al., 
2005b) 
C. dubia EC50 (7d population growth inhibition) 0.22 mg/L 
(Isidori et al., 
2005b) 
 P. subcapitata 
EC50 (72h growth 
inhibition) 0.02 mg/L 
(Isidori et al., 
2005b) 
 P. subcapitata 
EC50 (72h growth 
inhibition) 0.037 mg/L 
(Eguchi et al., 
2004) 
 P. subcapitata 
NOEC (72h growth 
inhibition) 0.01 mg/L 
(Eguchi et al., 
2004) 
Sulfamethoxazole D. magna EC50 (48h immobilization) 189 mg/L 
(Kim et al., 
2007b) 
V. fischeri 
EC50 (15 min, 
inhibition in 
luminescence)  
78 mg/L (Kim et al., 2007b) 
D. magna EC50 (24h immobilization) 25.2 mg/L 
(Isidori et al., 
2005b) 
C. dubia EC50 (24h immobilization) 15.5 mg/L 
(Isidori et al., 
2005b) 
C. dubia EC50 (7d population growth inhibition) 0.21 mg/L 
(Isidori et al., 
2005b) 
P. 
subcapitata 
EC50 (72h growth 
inhibition) 0.52 mg/L 
(Isidori et al., 
2005b) 
P. 
subcapitata 
EC50 (72h growth 
inhibition) 1.53 mg/L 
(Eguchi et al., 
2004) 
D. magna EC50 (48h immobilization) 123 mg/L 
(Park and 
Choi, 2008) 
Erythromycin was found to be the most ecotoxic antibiotic in the literature.  
Different species responded differently to antibiotics.  Crustaceans (D. magna and C. 
dubia) are more resistant to ecotoxicological effects of antibiotics than algae (P. 
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subcapitata).  Among crustaceans C. dubia is more sensitive.  While acute effects of 
antibiotics were at mg/L levels, chronic effects ware observed at µg/L levels. 
The main property of β-blockers is inhibition of β-receptors which are responsible 
for sympathetic responses (e.g., heart rate increase) in vertebrates.  While 
propranolol inhibits both of the β1 and β2 receptors, atenolol inhibits only β1 
receptors (Santos et al., 2010).  Although invertebrates such as algae do not possess β 
receptors they have been affected by β-blockers.  Moreover, vertebrates’ chronic 
exposure of β-blockers may cause drastic effects such as heart and liver failure 
(Table 2.6).  
Table 2.6: Literature survey on ecotoxicological effects of studied β-blockers. 
Compound Species Toxicological Endpoint 
Ecotoxicity 
Data Reference 
Atenolol D. magna EC50 (48h immobilization) 313 mg/L (Cleuvers, 2005) 
P. 
promelas 
NOEC (28d growth 
inhibition) 3.2 mg/L 
(Winter et al., 
2008) 
P. 
promelas 
NOEC (21d 
reproduction) 10 mg/L 
(Winter et al., 
2008) 
Propranolol D. magna EC50 (48h immobilization) 7.5 mg/L (Cleuvers, 2003) 
D. magna LC50 (48h mortality) 1.6 mg/L (Huggett et al., 2002) 
H. azteca LC50 (48h mortality) 29.8 mg/L (Huggett et al., 2002) 
H. azteca NOEC (24d reproduction) 1 µg/L 
(Huggett et al., 
2002) 
C. dubia LC50 (48h mortality) 0.8 mg/L (Huggett et al., 2002) 
 C. dubia NOEC (7d reproduction) 0.125 mg/L 
(Huggett et al., 
2002) 
 D. magna NOEC (9d body mass) 0.22 mg/L 
(Dzialowski et 
al., 2006) 
Atenolol and propranolol have very different effects to organisms even though they 
are member of same therapeutic group.  It may be due to propranolol’s blocking of 
both β-receptors while atenolol blocks only one β-receptor.   
Estrogens are mostly reported hormones existing in environmental waters.  It is 
known that they have vitellogenin synthesis, vitelline envelope (eggshell) protein 
production, gonadal differentiation, development of secondary sexual characteristics, 
GnRH and gonadotropin secretion, oestrogen receptor synthesis, pheromonal 
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communication, bone formation and calcium homeostasis effects to fish (Larsson et 
al., 1999).  Vitellogenin concentrations can be found in the blood plasma of male fish 
when they had been exposed to estrogens.  High concentrations of vitellogenin in the 
blood plasma of male fish causes feminization or simultaneous occurrence of male 
and female gonadal characteristics (Jobling et al., 1998).  
Oral contraceptive pills contain synthetic estrogen, EE2 which has highest endocrine 
disruptive effect among estrogen hormones (Larsson et al., 1999).  Chronic exposure 
of fathead minnows to EE2 at concentrations lower than 1 ng/L causes higher egg 
production but lower fertilization.  Concentrations over 3.5 ng/L of EE2 causes 
totally feminization of all of the male fish (Parrott and Blunt, 2005; Santos et al., 
2010) (Table 2.7).  
Table 2.7: Literature survey on ecotoxicological effects of studied hormones.  
Compound Species Toxicological Endpoint 
Ecotoxicity 
Data Reference 
E2 
O. latipes 
NOEC (21d 
testis-ova 
induction) 
<29.3 ng/L (Kang et al., 2002) 
EE2 
P. promelas 
LOEC (21d 
plasma VTG 
induction) 
1 ng/L (Pawlowski et al., 2004) 
D. rerio 
LOEC (38d 
plasma VTG 
induction) 
2 ng/L (Orn et al., 2003) 
Estrogenic responses of hormones were detected using ER-CALUX and YES tests.  
It is reported that EE2 had 1.2 estradiol equivalent estrogenicity in both of the tests.  
While 0.1 estradiol equivalent estrogenicity was found in YES test, it was 0.056 
estradiol equivalent in ER-CALUX for E1 (Murk et al., 2002).   
NSAIDs are responsible to inhibit cyclooxygenase enzymes, COX-1 and COX-2.  
Since fish have a cyclooxygenase enzymes resembling human COX-2 enzyme, they 
might be affected directly or via food web by NSAIDs (Santos et al., 2010). 
Diclofenac, ibuprofen, and naproxen have different effects on aquatic organisms 
(Table 2.8). 
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Table 2.8: Literature survey on ecotoxicological effects of studied hormones. 
Compound Species Toxicological Endpoint 
Ecotoxicity 
Data Reference 
Diclofenac D. magna EC50 (48h immobilization) 72 mg/L 
(Cleuvers, 
2003) 
D. magna EC50 (48h immobilization) 68 mg/L 
(Cleuvers, 
2004) 
D. magna EC50 (48h immobilization) 22 mg/L 
(Cleuvers, 
2003) 
D. magna EC50 (48h immobilization) 108 mg/L 
(Cleuvers, 
2003) 
P. subcapitata NOEC (96h growth inhibition) 10 mg/L 
(Ferrari et 
al., 2003) 
D. subcapitatus EC50 (growth inhibition) 72 mg/L 
(Cleuvers, 
2003) 
C. dubia EC50 (48h immobilization) 22 mg/L 
(Ferrari et 
al., 2003) 
C. dubia NOEC (7d reproduction) 1 mg/L 
(Ferrari et 
al., 2003) 
 D. rerio NOEC (10d survival) 4 mg/L 
(Ferrari et 
al., 2003) 
Ibuprofen D. magna EC50 (48h immobilization) 108 mg/L 
(Cleuvers, 
2003) 
D. magna EC50 (48h immobilization) 10-100 mg/L 
(Heckmann 
et al., 2007) 
D. magna EC50 (14d reproduction) 13.4 mg/L 
(Heckmann 
et al., 2007) 
D. subcapitatus EC50 (growth inhibition) 315 mg/L 
(Cleuvers, 
2003) 
D. subcapitatus EC50 (growth inhibition) 342 mg/L 
(Cleuvers, 
2004) 
O. lapites LC50 (96h mortality) >100 mg/L 
(Pounds et 
al., 2008) 
Naproxen D. magna EC50 (48h immobilization) 174 mg/L 
(Cleuvers, 
2003) 
D. magna EC50 (48h immobilization) 166 mg/L 
(Heckmann 
et al., 2007) 
C. dubia EC50 (24h immobilization) 66 mg/L 
(Isidori et al., 
2005a) 
C. dubia NOEC (7d reproduction) 0.33 mg/L 
(Ferrari et 
al., 2003) 
P. subcapitata NOEC (72h growth inhibition) 32 mg/L 
(Isidori et al., 
2005a) 
 D. subcapitatus EC50 (growth inhibition) 626 mg/L 
(Cleuvers, 
2004) 
There are few studies in the literature on mixture effects of pharmaceuticals and 
hormones.  Some of them indicate mixture of pharmaceuticals may exert additive 
effects (DeLorenzo and Fleming, 2008).  On the other hand,  (Cleuvers, 2003) 
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showed synergistic interaction between diclofenac and ibuprofen during D. magna 
immobilization test.  Moreover, D. magna immobilization was observed for 
acetylsalicylic acid, diclofenac, ibuprofen, and naproxen mixture even all of them are 
at concentrations which they do not affect D. magna when they are single (Cleuvers, 
2004).  These studies are very limited and do not provide general information on 
interactive effects of pharmaceuticals and hormones. 
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3. MATERIALS AND METHOD 
Experimental approach of this study consisted of two main elements which are field 
study and laboratory study (Figure 3.1). 
3.1 Sampling 
3.1.1 Description of the watershed 
İstanbul with its population over 10 million and average rate of population increase 
of 4.9% is one of the greatest metropolitan cities in the world (Maktav and Erbek, 
2005).  Due to climate change and global warming as well as the huge amount of 
migration it receives, local authorities and central government face a challenge with 
supplying drinking water to the residents of Istanbul and meeting the required 
demands of drinking water quality.  For instance, between 1998 and 2007, the 
amount of water supplied per year increased from 598,742,000 m3 to 732,051,000 m3. 
Over 90% of the water demand of İstanbul is supplied from surface water, currently 
from six drinking water reservoirs.  Of the six watersheds that supply drinking water, 
three are located on the European side (Terkos, Büyükçekmece, and Alibeyköy) and 
three on the Asian side (Ömerli, Darlık, and Elmalı) of the city (Figure 3.2). 
Moreover, there are minor drinking water resources such as Istırancalar, Sazlıdere, 
Pabuçdere, and Kazandere creeks. 
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Figure 3.1: Experimental approach of the study.
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Figure 3.2: Drinking water watersheds of Istanbul. 
Büyükçekmece Lake, covering 27.5 km2 area and lying in 620 km2 watershed, is the 
third important water source for İstanbul making the lake and its watershed very 
important for inhabitants of İstanbul (Table 3-1). 
Table 3.1: Extractable water amounts of drinking water resources of Istanbul in 2008. 
Reservoir Extractable Water in May 2008 (million m3) 
Ömerli 91 
Terkos 130 
Büyükçekmece 70 
Darlık 32 
Alibeyköy 6 
Elmalı 6 
Sazlıdere 16 
Istırancalar 1 
Kazandere 0.1 
Pabuçdere 0.7 
After 2008, water extracted from Melen River started to be used in Istanbul.  The 
annual amount of water brought from Melen depends on rain rate and changed 
between 2 million m3 and 134 million m3 from 2008 to 2012.   
Büyükçekmece Watershed is one of the important migration taking areas in Istanbul.  
Today, approximately 180,000 inhabitants live in the watershed and its projected 
population for 2020 is 260,000 (Baykal et al., 2000).  Most of the inhabitants live in 
the long range protection zone (i.e. area corresponding to 2000 m to watershed 
boundary from the lake).  However, there are some small communities living in the 
absolute protection zone due to unplanned urbanization although it is banned by 
regulations.  
Alibeyköy 
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The most recent study on land use of the watershed was 2000 indicating 12% of the 
area was residential and industrial (Maktav and Erbek, 2005).  However, considering 
the population increase, increase in these areas is most likely.   
There are five main tributaries flowing into Büyükçekmece Lake: Beylikçayı, Karasu, 
Hamza, Tahtakoprü, and Ahlat (Figure 3.3).  Karasu is the greatest one with 70 km 
approximate length and 275 km2 sub-watershed.  Karasu passes through Çatalca 
which is the greatest town in the watershed and found as having 4th degree water 
quality regarding N and P in Water Pollution Control Regulation (Gönenç, 1995).  
 
Figure 3.3: Büyükçekmece Watershed. 
Büyükçekmece Lake was designated as polluted surface water in Istanbul City 
Environmental Situation Report.  Residents, industries, erosion, and agriculture were 
considered as main pollution sources (İÇDR, 2007).  In addition, Büyükçekmece 
Lake was found 3rd class regarding organic parameters, 4th class regarding inorganic 
parameters, and 2nd class regarding biological parameters according to the 
classification in Water Pollution Control Regulation (Baykal et al., 2000).   
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According to the data obtained by Istanbul Water and Sewerage Administration in 
2006, there are 287 industries in the watershed.  Most of the industries are in food, 
metal, chemistry, textile, leather, and petroleum industrial categories.  Moreover, 
only 30% of them have wastewater treatment plant.  Nevertheless, while 16 of the 
industries are placed in the lake absolute protection zone, 60 of them are in river 
absolute protection zone.  
Büyükçekmece Water Treatment Plant lies at the southeast of the lake.  Capacity of 
the treatment plant is 400,000 m3/day.  The quality of the treated water has been 
routinely checked by Istanbul Water and Sewerage Administration and published 
monthly reports.  It is stated in these reports that treated water of the water treatment 
plant meets all drinking water standards.  However, no emerging pollutants in 
particular pharmaceuticals and hormones are included in these standards.  Therefore, 
pharmaceuticals and hormones are not monitored in untreated and treated water of 
the watershed.  Consequently, there is no information on environmental and human 
health risks posed by pharmaceuticals and hormones in this area. 
3.1.2 Sampling sites 
Grab samples were taken from six different stations, five on each main tributary and 
one on the lake (Figure 3.4).   
 
Figure 3.4: Sampling points. 
Sampling points on the tributaries were determined as close as possible to the lake to 
be able to monitor all pollution loads flowing into the lake.  Sampling point on the 
lake was selected as close as possible to water intake structure of the water treatment 
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plant.  Sampling was made five different times in a year (December, March, May, 
July, October) to examine seasonal changes.  
3.2 Compound selection 
Pharmaceuticals to be monitored should be selected according to their consumptions, 
excretion rates and types.  There were around 21,000 pharmacies in Turkey in 2003.  
In the pharmaceutical sector, there are 87 manufacturing firms, 11 raw material 
manufacturers, and 38 importing firms, summing up 136 firms.  The top ten 
bestselling pharmaceutical preparations account for 40% of the total market.  
Antibiotics, analgesics, and antirheumatic preparations are the most sold 
pharmaceuticals in 2005 in terms of boxes of drugs sold (Kisa, 2006).  However, 
“boxes of drugs sold” is not a proper unit for estimating the drug use, since it does 
not provide information on the “mass” of active ingredient of the drug. 
The pharmaceutical usage rates between October 2005 and October 2007 in Days of 
Therapy (DOT) unit is provided in Table 3.2 along with World Health Organization 
(WHO) Anatomical Therapeutic Chemical (ATC) classification codes. 
DOT is a measure of pharmaceutical use that indicates direct measure of the number 
of days of therapy.  One DOT represents the administration of a single agent on a 
given day regardless of the number of doses administrated or dosage strength.  Polk 
et al. (2007) indicated that DOT methodology is a superior measure of use and can 
be used to compare relative uses of different pharmaceuticals (Polk et al., 2007). 
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Table 3.2: Pharmaceutical usage rates in DOTs. 
Therapeutic Class DOT 
M01 ANTIRHEUMATIC SYSTEM 1,124,269,015 
A02 A-ACID A-FLAT A-ULCERANTS 894,334,215 
J01 SYSTEMIC ANTIBACTERIALS 873,980,787 
B03 ANTIANAEMICS 767,845,588 
A10 DRUGS USED IN DIABETES 765,560,971 
R01 NASAL DECONG/ANTIINFECT. 748,137,864 
H03 THYROID THERAPY 716,004,419 
C10 LIPID-REG/ANTI-ATHEROMA 638,142,697 
N06 PSYCHOANALEPTICS 629,244,137 
C09 RENIN-ANGIOTEN SYST AGENT 625,492,084 
C08 CALCIUM ANTAGONISTS 445,432,491 
R05 COUGH & COLD PREPARATIONS 440,934,939 
G03 SEX HORMONES-SYSTEMC ONLY 424,310,288 
R03 ANTI-ASTHMA & COPD PROD 348,142,596 
A11 VITAMINS 322,928,483 
R06 ANTIHISTAMINES SYSTEMIC 294,112,997 
C01 CARDIAC THERAPY 259,822,230 
N02 ANALGESICS 237,636,959 
C07 BETA BLOCKING AGENTS 220,779,878 
G04 UROLOGICALS 168,353,661 
N05 PSYCHOLEPTICS 156,584,388 
C03 DIURETICS 146,425,081 
A03 FUNCTL.GI DISORDER DRUG 122,843,749 
N03 ANTI-EPILEPTICS 116,776,786 
B01 ANTITHROMBOTIC AGENTS 108,322,682 
Source: IMS Health Turkey (personal communication) 
Pharmaceuticals to be monitored were selected according to usage rates, excretion 
rates and types and hence the probable importance in the environment.  a total of ten 
pharmaceuticals including three NSAIDs, Diclofenac, Ibuprofen, Naproxen; four 
antibiotics amoxicillin, ciprofloxacin, erythromycin, and sulfamethoxazole; two β-
blockers, atenolol and propranolol; and one stimulant, caffeine were selected.  
Estrogen hormones estrone (E1), estradiol (E2), estriol (E3), and 17α-
ethynylestradiol (EE2) were also selected to observe their occurrence and fate in 
aquatic environment.  All of the compounds have different chemical and physical 
properties (Table 3.3 and Table 3.4).  Therefore, it is likely that they will have 
different behaviors in the environment. 
 38 
 
Table 3.3: Selected compounds and their main properties. 
Compound CAS No Use 
Molecular 
Weight 
(g/mol) 
Log 
Kow 
Excretion 
rate as 
unchanged 
compound 
(%) 
Amoxicillin 267-87-78-0 Antibiotic 365.4 0.97 80-902 
Ciprofloxacin 85721-33-1 Antibiotic 331.3 0.28 83.72 
Erythromycin 114-07-8 Antibiotic 734 3.06 152 
Sulfamethoxazole 723-46-6 Antibiotic 253.3 0.89 152 
Atenolol 29122-68-7 β-Blocker 266.3 0.16 903 
Propranolol 525-66-6 β-Blocker 259.3 3.48 <14 
Estrone (E1) 53-16-7 Hormone (Natural) 270.4 3.13 3-20
5 
17β-Estradiol (E2) 50-28-2 Hormone (Natural) 272.4 4.01 0.5-5
5 
Estriol (E3) 50-27-1 Hormone (Natural) 288.4 2.45 <64
5 
17α-Ethynylestradiol 
(EE2) 57-63-6 
Hormone 
(Synthetic) 296.4 3.67 40
6 
Diclofenac 15307-86-5 NSAID1 318.1 4.51 152 
Ibuprofen 15687-27-1 NSAID1 206.3 3.97 1-82 
Naproxen 22204-53-1 NSAID1 230.3 3.18 27 
Caffeine 58-08-2 Stimulant 194 -0.07 0.4-2.18 
1NSAID: Non-steroidal anti-inflammatory drug 
2(Jjemba, 2006) 
3(Zuccato et al., 2005) 
4(Ternes and Joss, 2006) 
5 typical daily excretion amount in μg/d, (Birkett and Lester, 2003) 
6(Johnson and Williams, 2004) 
7(Bougie and Aster, 2001) 
8(Birkett and Miners, 1991) 
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Table 3.4: Molecular structures of target compounds. 
Compound Molecular structure 
Amoxicillin 
 
Ciprofloxacin 
 
Erythromycin 
 
Sulfamethoxazole 
 
Atenolol 
Propranolol 
 
E1 
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Table 3.4 (continued): Molecular structures of target compounds. 
E2 
 
E3 
EE2 
Diclofenac 
Ibuprofen 
 
Naproxen 
 
Caffeine 
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3.3 Analytical Method 
3.3.1 Standards and reagents 
Target compounds were purchased from Sigma-Aldrich. All of them were of 
analytical grade, purity 95% or higher.  Among isotopically-labelled 
internal/surrogate standards, d2-Estradiol was purchased from Sigma-Aldrich, 13C2-
17α-Ethynylestradiol, d2-Ibuprofen, d7-Atenolol, d8-Ciprofloaxacin•HCl were 
purchased from C/D/N Isotopes.  Glass Oasis HLB cartridges (200 mg, 5 mL) were 
purchased from Waters Corporation and used for solid phase extraction (SPE). 
HPLC-gradient grade methanol, acetonitrile, acetone and methyl tert-butyl ether 
(MTBE) were obtained from Sigma-Aldrich as well as LC-MS grade formic acid. 25% 
NH4OH was supplied from Merck. High purity water (conductivity less than 
0.056 µS/cm3) was obtained from Sartorius Stedim Digitech Arium 611 UV model 
distilled water generator.  Nitrogen gas for analyte enrichment (99.995%) and argon 
(99.999%) were purchased from Linde Gas.  Nitrogen gas for nebulizing and 
desolvation (high purity) was provided by a nitrogen generator of Peak Scientific 
Instrument NM 30LA 230VOC. 
All stock standards were prepared in acetonitrile and stored in +4°C for three months 
except for antibiotics which were renewed monthly and stored in dark in amber 
bottles to avoid photodegradation.  Working solutions were prepared in water using 
stock solutions before each measurement.  
3.3.2 Sample preparation 
Samples were taken with Nalgene fluorinated jerricans.  All samples were filtered 
through 0.22 µm Whatman Polycap AS 75 filters within 24 hours after sampling. 
Oasis HLB cartridges are used for SPE of multi-residue analysis of pharmaceuticals 
in different therapeutic classes (Gracia-Lor et al., 2011; Gros et al., 2006; 2009).  The 
SPE cartridges were conditioned with 5 mL methyl tert-butyl ether, 5 mL acetone, 5 
mL methanol, 5 mL acetonitrile and 5 mL deionized water. One liter filtered sample 
was spiked with 40 µL of 2.5 mg/L surrogate/internal standard solution and then 
loaded on to SPE cartridges at 3-5 mL/min.  After sample loading, the cartridges are 
washed with 5 mL deionized water and dried under vacuum for 60 minutes.  The 
SPE cartridges were eluted with 5 mL methyl tert-butyl ether, 5 mL acetone, 5 mL 
methanol and 5 mL acetonitrile. The extracts then were evaporated until dryness 
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under gentle stream of nitrogen (0.5 bar) using Caliper TurboVap II system.  The 
analytes were reconstituted using 1 mL of 20:80 acetonitrile:water mixture. In 
addition, prior to loading the samples onto SPE cartridges, 1 g Na2EDTA was added 
to improve the extraction efficiency of antibiotics Gros et al. (2009). 
3.3.3 LC-MS/MS analysis 
LC-MS/MS analysis was conducted using a Thermo Electron Cooperation Accela 
UPLC coupled with TSQ Quantum Access triple quadrupole mass spectrometer with 
electronspray ionization (ESI).  A Thermo Hypersil Gold column (100 mm x2.1 mm 
i.d., 1.9 µm,) was used.  Although there may not be necessary chromatographic 
separation of target compounds during tandem mass spectrometric analysis, gradient 
elution was developed in order to prevent cross talks in MS.  Three mobile phase 
lines of UPLC were used for both negative ionization (NI) and positive ionization (PI) 
modes.  In each mode, one line was dedicated to the buffer solution and the 
percentage of this line was kept constant during the entire run.  Consequently, buffer 
was added to organic solvents and buffer capacity was kept stable during the whole 
run.  In the PI mode, mobile phase A, B, and C were 1% formic acid, acetonitrile and 
ultra-pure water, respectively.  In the NI mode, mobile phase A, B, and C were 50 
mM NH4OH, acetonitrile and ultra-pure water, respectively (Table 3.5).  400 µL/min 
flowrate and 25 µL injection volume were used in all runs.  While column 
temperature was set to 25°C, autosampler tray was kept at 10°C. 
Table 3.5: Gradient elution programs of LC. 
PI Mode NI Mode 
Time 
(min) A (%) B (%) C (%) 
Time 
(min) A (%) B (%) C (%) 
0 10 10 80 0 20 15 65 
8 10 90 0 4.5 20 80 0 
8.7 10 90 0 5 20 80 0 
9 10 20 70 5.5 20 15 65 
12 10 20 70 8 20 15 65 
Compound dependent MS parameters (spray voltage (SV), sheath gas pressure (SGP), 
auxiliary gas pressure (AGP), ion sweep gas pressure (ISGP), capillary temperature 
(CT), tube lens offset (TLO), collision energy (CE), and collision pressure (CP)) and 
two transition ions were detected via direct infusion of 500 µg/L of each compound 
at a flow rate of 10 µL/min using the syringe pump of the MS.  In order to achieve 
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better sensitivity, different time segments were used which also lead to higher 
number of points per chromatographic peak.  Common MS/MS parameters for the PI 
mode were SV: 5000 V; CT: 250°C; SGP: 30 arb; ISGP: 4 arb; AGP: 5 arb; ST: 50 
ms; SW: 0.2 m/z; whereas they were determined as SV, -3500 V; SGP, 40 arb; ISGP, 
2 arb; AGP, 20 arb; ST, 50 ms; SW, 0.01 m/z for the NI mode.  Segment specific 
parameters, scan time intervals, SRM transitions and retention times were provided 
in Table 3.6. 
Two transition ions were selected to use in SRM for each compound of interest 
except Ibuprofen which yields only one transition ion during triple quadrupole mass 
spectrometry due to poor fragmentation (Gros et al., 2009).  The transition ion with 
the higher intensity was used for quantification (first transition in Table 3.6) and the 
other ion was used for confirmation (second transition in Table 3.6) to eliminate false 
positives (Schlusener and Bester, 2005).  Only one transition ion was used for 
internal/surrogate standards, since they are not naturally found in environmental 
waters. d2-Estradiol was used as surrogate/internal standard for quantification of  E1 
and E2, 13C2-17α-Ethynylestradiol was used as surrogate/internal standard for 
quantification of EE2 and E3, d2-Ibuprofen was used as surrogate/internal standard 
for quantification of  Ibuprofen, Naproxen and Diclofenac, d7-Atenolol was used as 
surrogate/internal standard for quantification of  Atenolol, Propranolol and Caffeine, 
and d8-Ciprofloaxacin was used as surrogate/internal standard for quantification of 
Sulfamethoxazole, Ciprofloxacin, Amoxicillin and Erythromycin.  
To calculate recoveries during the SPE, ultra-pure water and one of the samples were 
spiked with different concentrations (10 ng/L and 100 ng/L, n=3 for each) of target 
compounds and each spiked sample were extracted using the proposed SPE 
procedure and analyzed.  To eliminate the effect of the presence of target compounds 
in the sample prior to spiking non-spiked samples were also extracted and analyzed.  
Concentrations determined in non-spiked samples were subtracted from the 
concentrations of spiked samples during the calculation of the recovery  
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Table 3.6: Segment specific parameters, scan time intervals, SRM transitions, and 
retention times. 
Compound 
Time 
Segment 
(minute) 
Retention 
Time 
(minute) 
SRM 
transition TLO CE 
Positive Ionization      
Amoxicillin 0-1.8 1.19 366.2=>114.11366.2=>160.41 80 18 
Ciprofloxacin 1.8-3.2 2.67 332.1=>287.83332.1=>230.95 100 15 
Erythromycin 3.2-7 4.89 716.5=>558.45716.5=>157.95 68 20 
Sulfamethoxazole 3.2-7 3.57 253.9=>155.92253.9=>108.11 68 20 
Atenolol 0-1.8 0.86 267.1=>190.07267.1=>145.07 80 18 
Propranolol 3.2-7 4.17 260=>155.07 260=>183.07 68 20 
Caffeine 1.8-3.2 2.12 195=>138 195=>110 100 15 
d7-Atenolol 0-1.8 0.86 274.1=>191.90 80 18 
d8-Ciprofloaxacin 1.8-3.2 2.67 340.1=>296.15 100 15 
 
Negative Ionization      
Diclofenac 0-2.5 2.14 294=>249.90 294=>214.02 50 12 
Ibuprofen 0-2.5 1.86 205.4=>161.4 50 12 
Naproxen 0-2.5 1.02 229.3=>170.1 229.3=>169.1 50 12 
d2-Ibuprofen 0-2.5 1.86 208.2=>164.2 50 12 
E1 2.5-6 4.75 269=>145.07 269=>143.24 105 40 
E2 2.5-6 4.48 271.1=>182.96271.1=>145.12 105 40 
E3 2.5-6 3.11 287=>170.87 287=>145 105 40 
EE2 2.5-6 4.68 295=>145.1 295=>185.1 105 40 
d2-E2 2.5-6 4.48 173=>147.2 105 40 
13C2-EE2 2.5-6 4.68 297=>159 105 40 
3.4 Ecotoxicological Experiments 
The effects of the target compounds were determined using several ecotoxicological 
bioassays in this study.  Experiments were designed to obtain information on lethal 
and sub-lethal effects of single compounds as well as on the possible effect when the 
compounds coexist as a mixture.  Moreover, since the determination of 
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ecotoxicological effects of chemicals to a single species do not provide enough 
information, four different species are used to determine four different effects (i.e. 
acute, chronic, mutagenic, and estrogenic) of target compounds.  While acute effects 
were determined using P. subcapitata (freshwater algae growth inhibition test) and D. 
magna (immobilization test), only D. magna is used for the determination of chronic 
effects (reproduction test).  Mutagenicity was determined using the AMES test 
(mutant S. tphidyum).  YES test (recombinant S. cerevisiae) was used for 
determination of estrogenic effects.   
All ecotoxicological experiments were conducted using synthetic solutions of target 
compounds and all solutions were prepared in water media proper for the test 
conducted.   
3.4.1 Acute toxicity tests 
Pseudokirchneriella subcapitata and Daphnia magna were used in acute toxicity 
tests.  Both of the species are ecologically important.  P. subcapitata are unicellular 
freshwater green algae.  They are primary producers like all other green algae species.  
Therefore, any adverse effects to them threaten the whole ecosystem.  P. subcapitata 
are one of the recommended species by OECD in its standard for ecotoxicity tests.  
Since they are commonly used for ecotoxicity assays, they are commercially 
available.  D. magna are freshwater crustacean.  They occupy an important part of 
the food web.  They are predators of primary producers and prey of carnivore aquatic 
animals.  Therefore, any adverse effects on them may pose threat to both primary 
production process and carnivores.  D. magna are also a commonly used species for 
ecotoxicity tests and are commercially available.  Both of the species have different 
sensitivities to different chemicals.  Although P. subcapitata are considered more 
sensitive than D. magna, it is not valid for all of the chemicals.  However, their 
sensitivities are good enough to be used in ecotoxicological studies.  
3.4.1.1 Daphnia magna acute immobilization test 
Acute immobilization tests of water flea D. magna were conducted according to the 
OECD 202 standard (OECD, 2004).  24-hour and 48-hour exposure times were used 
as recommended in the standard method.  D. magna populations were incubated 
under standard conditions to establish that the only variable is the test material.  First 
brood of the population was not used as recommended in the standard.  D. magna 
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incubation media consists of four stock solutions: 11.76g CaCl2·2H2O was dissolved 
in 1 liter distilled water, 4.93 g MgSO4·7H2O was dissolved in 1 liter distilled water, 
2.59g NaHCO3 was dissolved in 1 liter distilled water, 0.23g KCl was dissolved in 1 
liter distilled water.  25 mL of each solution were mixed and made up to 1L with 
distilled water and oxygenated to prepare media.  This media has a hardness of 140-
250 mg CaCO3/L, a pH of 7.8, a Ca/Mg molar ratio of approximately 4, and a 
dissolved oxygen concentration above 7.  Other important variables in the test are the 
light and temperature.  During incubation, the population kept in a 16-hour light (800 
lux intensity) and 8-hour dark cycle.  On the other hand, tests were conducted  in 
dark.  All incubations and tests were conducted in a constant temperature room 
having a temperature of 20±2°C.  Populations were fed with P. subcapitata and yeast 
during incubation.   
Members of the population younger than 24 hours were exposed to different 
concentrations of compounds in four replicates in vessels designated for this test.  In 
each replicate 5 individuals were used.  All solutions of the test compounds as well 
as dilutions were prepared in the media of D. magna.  A dilution-water control was 
also conducted for each test.  
All test results were examined using SigmaPlot statistical program and different end 
points (EC10, EC50, EC80 and if possible NOEC and LOEC) were estimated via 
plotting the appropriate curve using appropriate non-linear regression method (e.g. 
probit, weibull). 
3.4.1.2 Freshwater algae growth inhibition test 
Although growth inhibition tests of freshwater algae were using P. subcapitata is 
considered as an acute toxicity test, it is called as semi-chronic or chronic toxicity 
test in some test protocols and standards depending on the test duration.  The test 
duration, or the exposure time, may be the main difference between acute and 
chronic tests, but it is not the only factor.  In chronic tests, covering important part of 
life span of test organisms and conducting tests in semi-static or continuous are 
essential to observe chronic effects.  Since freshwater algae tests were conducted 
static and in 72-hour exposure time, it is called as acute toxicity test in this study.  
P. subcapitata populations were grown in a media recommended in the standard 
(Table 3.7). 
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Table 3.7: Algae growth medium stock solutions. 
Nutrients Concentration in stock solution (mg/L) 
Stock solution 1: macro nutrients  
NH4Cl 1500 
MgCl2·6H2O 1200 
CaCl2·2H2O 1800 
MgSO4·7H2O 1500 
KH2PO4 160 
Stock solution 2: iron  
FeCl3·6H2O 64 
Na2EDTA·2H2O 100 
Stock solution 3: trace elements  
H3BO3 185 
MnCl2·4H2O 415 
ZnCl2 3 
CoCl2·6H2O 1.5 
CuCl2·2H2O 0.01 
Na2MoO4·2H2O 7 
Stock solution 4: bicarbonate  
NaHCO3 50000 
While stock solutions 1 and 3 were sterilized by autoclaving, 2 and 4 are filter-
sterilized by membrane filters with a pore diameter 0.2 µm.  To prepare th final 
growth medium 10 mL of the stock solution 1 and 1 mL of each of the stock 
solutions 2, 3, and 4 are added to 500 mL sterilized distilled water and finally made 
up to 1 L with sterilized distilled water.  The prepared growth medium was left under 
open air in a laminar flow chamber for equilibration with atmospheric CO2.  All 
stock solutions were kept in amber glass bottles at 4°C.  Solutions and dilutions of 
test substances were also prepared in the growth medium. 
Incubation of P. subcapitata and tests were conducted in a temperature controlled 
room having a temperature 20±2°C.  Constant/continuous light was provided with 
uniform daylight type florescent illumination.  Light intensity was kept 6000 lux 
which is in the range of recommended light intensity (4440-8880 lux). 
Algal biomass is used to compute growth and growth inhibition during a period of 
time.  Dry weight of the algal population must be measured to find algal biomass.  
Since it is difficult to measure dry weight in particular this kind of bioassays due to 
very low weight, some other parameters such as cell counts are often used. In this 
study, cell counts were used as surrogate parameter to estimate growth inhibition.  
Cells were counted using a hemocytometer and an Olympus microscope (40x).  
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Exponentially growing test organisms were exposed to various dilutions of target 
compounds for 72-hour under certain conditions.  Responses were evaluated in 
comparison with growth of exposed organisms and unexposed control cultures.  All 
experiments were conducted with four replicates.   
Each replicate of each dilution was inoculated with 1x104 cells/mL (initial cell 
concentration).  Inoculums used in the tests were prepared 2-4 days before the tests 
to let the population reach exponential growth phase and adapt alga to test conditions.   
The system response is the reduction of growth in a series of algal cultures (test units) 
exposed to various concentrations of a test substance.  The response is evaluated as a 
function of the exposure concentration in comparison with the average growth of 
replicate, unexposed control cultures.  For full expression of the system response to 
toxic effects (optimal sensitivity), the cultures are allowed unrestricted exponential 
growth under nutrient sufficient conditions and continuous light for a sufficient 
period of time to measure reduction of the specific growth rate (OECD, 2006). 
Specific growth rate was calculated as: 
ߤ௜ି௝ ൌ ln ௝ܺ െ ݈݊	 ௜ܺݐ௝ െ	ݐ௜  
where: 
μi-j is specific growth rate between i and j 
Xi is the biomass at time i 
Xj is the biomass at time j 
The percent inhibition of the growth rate was calculated as: 
%ܫ௥ ൌ ߤ௖ െ	ߤ௧ߤ௖ ݔ100 
where: 
%Ir: percent inhibition in average specific growth rate 
µc: mean value for average specific growth rate in the control group 
µt: average specific growth rate for the treatment replicate 
(3.1) 
(3.2) 
 49 
 
3.4.2 D. magna reproduction test 
This test was used to predict effects of chemicals on the reproductivity of D. magna.  
Less than 24-hour old female D. magna individuals were exposed to different 
concentrations of target compounds for 21 days.  The total number of living 
offspring produced per parent animal alive at the end of the test was used to assess 
effects.  The reproductivity of exposed animals was compared with the 
reproductivity of animals in the control groups to estimate the lowest observable 
effect concentrations (LOEC), no observable effect concentrations (NOEC) as well 
as the ECx values where available.   
The same growth medium with the acute immobilization test described in 3.4.1.1 was 
used.  The test solutions and dilutions were prepared in the same medium.   
10 animals were maintained individually in 100 mL beakers containing 50 mL 
solutiion for each concentration.  The tests were conducted in semi-static manner 
feeding all test animals daily with P. subcapitata and yeast as well as changing 
solutions three times in a week.  To each animal, 0.1-0.2 mg C/day which is 
sufficient to achieve enough offspring to end the test was fed.   
During incubation, the test animals kept in a 16-hour light (800 lux intensity) and 8-
hour dark cycle.  All incubations and tests were conducted in a constant temperature 
room having a temperature of 20±2°C.   
During 21-day period, number of offspring in each beaker, number of dead parents, 
and any possible stress indicating anomalies such as losing color of the animals were 
noted (OECD, 1998). 
3.4.3 AMES test 
AMES test is the most widely used and accepted mutagenicity test based on bacterial 
reverse-mutation.  The test employs a mutant strain, or several strains, of Salmonella 
typhimurium, carrying mutation(s) in the operon coding for the amino acid, histidine, 
biosynthesis.  When these bacteria are exposed to mutagenic agents, reverse mutation 
from histidine auxotrophy to prototrophy occurs.  Traditionally, reverse-mutation 
assays have been performed using agar plates, known as “pour plate”, “plate-
incorporation” or “agar-overlay” assays (Ames et al., 1975).  An alternate assay 
performed entirely in liquid culture is the `Fluctuation test', originally developed by 
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Luria and Delbruck (1943) and was modified by Kilbey (1984).  In this study, The 
Muta-ChromoPlateTM kit with TA100 mutant strains to perform the Fluctuation test 
was used. 
All essential chemicals, growth media and test strains were provided with the kit.  
One day before the test lyophilized bacteria was reconstituted with nutrient broth 
supplied with the kit and incubated for 16-18 hours at 37°C.  Reconstituted bacteria 
should have turbid yellowish color (Figure 3.5).   
 
Figure 3.5: Reconstituted bacteria for AMES test. 
On the test day samples were sterilized using membrane filters with 0.22 µm pore 
sizes.  17.5 mL of filtered samples were transferred to sterile falcon tubes.  A 
reaction mixture consisting 21.62 mL concentrate Davis-Mingioli salts, 4.75 mL D-
glucose, 2.38 mL Bromocresol Purple, 1.19 mL D-Biotin, 0.06 mL L-Histidine was 
prepared.  2.5 mL of reaction mixture were added to each sample, negative control, 
positive control and background.  5 µL of incubated and well mixed S. typhimurium 
test-strain broth culture were added to each treatment tube except negative control.  
Contents of the each tube were transferred to a sterile multichannel pipette reagent 
boat.  200 µL of the mixtures were dispensed into each well of a 96-well 
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microtitration plate using a multichannel pipette.  At the beginning, color of each 
well must be purple.  Well-plates were incubated for 5 days at 37°C.   
In this test, negative control was used to determine whether there had been bacterial 
contamination in solutions.  A well-known mutagen NaN3 was used as positive 
control to control if the bacteria work.  During replication of S. typhimurium natural 
reverse mutations may occur.  To characterize how much natural reverse mutation 
occurs, background control was used.  In background control, non-mutagen sterile 
distilled water was used as sample. 
After 5 days all well-plates were observed.  If reverse mutation had occurred, the 
bacteria had ability to synthesize histidine and consequently, caused color turned 
from purple to yellow.   
Fluctuation test is based on comparison of number of the yellow wells in samples 
and number of yellow wells in background.  If there is a statistically significant 
increase in the number of yellow wells in sample plate than the number of yellow 
wells in background plate, the sample is designated as mutagen. 
3.4.4 YES test 
A recombinant yeast strain, Saccharomyces cerevisiae, which can interact with the 
human estrogen receptor (hER) was used in Yeast Estrogen Screen Tests (YES).  
Normally, there is not any estrogen receptor in yeast cells.  Therefore, the DNA 
sequence of hER should be stably added to their main chromosome.  The receptors’ 
activity is detected using expression plasmids carrying the reporter gene lac-Z 
(encoding the enzyme b-galactosidase) which is naturally contained in the yeast cells. 
The biochemical reactions during the test were best explained in Jobling et al. (1996) 
and Isidori et al. (2006) as: In this system, the hER is expressed in a form capable of 
binding to estrogen-responsive sequences (ERE).  These sequences were situated 
within a strong promoter sequence on the expression plasmid.  Upon binding an 
active ligand, the estrogen-occupied receptor interacts with transcription factors and 
other transcriptional components to modulate gene transcription.  This causes 
expression of the reporter gene lac-Z and the enzyme produced (b-galactosidase) is 
secreted into the medium, where it metabolizes the chromogenic substrate, ortho-
nitrophenyl,β-D-galactopyranoside (ONPG), which is normally colorless, into a 
yellow product that can be measured by absorbance at 420 nm (Figure 3.6). 
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Figure 3.6: YES test main mechanism (Routledge and Sumpter, 1996). 
S. cerevisiae RMY326 strain which was kindly supplied by Luigi Mita from Second 
University of Naples, Italy was used in this study.   
The yeast cells, normally stored at -80°C, were reconstituted at 28°C with constant 
shaking at 200 rpm in a medium (Table 3.8) overnight. 
Table 3.8: Yeast medium for YES test. 
Substance Concentration 
Yeast Nitrogen Base 6.7 g/L 
Glucose 2% (w/v) 
Isoleucine (Ile) 30 mg/L 
Valine (Val) 250 mg/L 
Adenine (Ade) 50 mg/L 
Arginine . HCl (Arg.HCl) 20 mg/L 
Lysine . HCl (Lys.HCl) 30 mg/L 
Methionine (Met) 20 mg/L 
Phenylalanine (Phe) 50 mg/L 
Threonine (Thr) 200 mg/L 
Tyrosine (Tyr) 30 mg/L 
Histidine . HCl (His.HCl) 200 mg/L 
Leucine (Leu) 100 mg/L 
After 16-18 hours the yeasts reached exponential growth phase.  The yeasts having 
concentration of 2x107 cells/mL were incubated in the presence of the target 
compounds for another 16-18 hours at 28°C.  Duplicates of five different 
concentrations were used for each compound as well as each mixture to obtain data 
for statistical evaluation of endpoints.  Along with target compounds a blank and the 
duplicates five different concentrations of E2 (1x10-5 – 1x10-9 M) were added to each 
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test as positive control.  Consequently, interferences caused by any contaminations 
and daily fluctuations on standard (E2) values were avoided.   
After second incubation, 1 mL of the samples as well as blank and standards were 
centrifuged at 4000 rpm for 5 minutes and the supernatant was discarded. The yeast 
cells were re-suspended in 150 µL z-buffer (30 mM Na2HPO4, 20 mM NaH2PO4, 
5mM KCl, 0.5 mM MgSO4, 0.025% (v/v) b-mercaptoethanol).  50 µL of re-
suspensions were taken to small vials and 50 L CH2Cl2, 20 µL SDS and 30 µL z-
buffer were added for permeabilization of cell membranes.  The vials were vortexed 
for 10 seconds and incubated at 28°C for 5 minutes.  700 µL ONPG (4mg/mL in z-
buffer) were added to each vial for chromogenic reaction and all vials were incubated 
at 28° C.  After approximately 5 minutes, chromogenic reaction was stopped by the 
addition of 500 µL of 1 M Na2CO3.  All vials were centrifuged at 14000 rpm for 5 
minutes and the absorbance at 420 nm was measured.  In the final step, absorbance 
of 1 mL of non-centrifuged samples after second incubation at 600 nm was measured 
to determine cell density in the incubation tubes.  The results of the tests were 
presented as Miller Unit (MU) calculated as:  
ܯܷ ൌ ܱܦସଶ଴ݔ1000ݐݔܸݔܱܦ଺଴଴  
where: 
MU: Miller Unit 
OD420: absorbance at 420 nm 
OD600: absorbance at 600 nm 
t: chromogenic reaction time  
V: Volume of the culture used in the test (50 µL in this case) 
The Relative Inductive Efficiency (RIE) which is the estrogenic activity of the tested 
compound relative to E2 was determined as the ratio of the maximal β-galactosidase 
activity induction with test compound to E2×100. 
YES test was not conducted for hormones since their estrogenic effect is natural. 
(3.3) 
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3.5 Statistical Analysis 
All data obtained in the experiments were treated with proper statistical analysis.  
Analytical measurements during the occurrence study were conducted in duplicates 
and samples were injected triplicates to be able to calculate standard deviations.  All 
experiments and injections were made in triplicates to determine the detection limits 
of analytical methods. 
Acute toxicity, chronic toxicity, and YES tests were conducted in four, ten, two 
replicates, respectively.  For the AMES Test, a statistical approach designed in 
particular for this test, fluctuation test, was used (Luria and Delbruck, 1943).   
Linearization of plots with logarithmic scale used to be the most commonly used 
technique for calculation of ECx values.  However, non-linear regression analysis 
has recently become more popular to treat ecotoxicological data due to enhanced 
robustness of the non-linear regression and the development of computerized tools 
for curve fitting.  Therefore, non-linear regression was used with the help of a 
computer program (i.e. SigmaPlot) in this study.  Appropriate non-linear regression 
method (e.g. probit, weibull, sigmoidal) was selected according to the fitting of the 
curves to ecotoxicology data.  The LOEC and hence the NOEC were estimated using 
the ANOVA analysis.  
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4. RESULTS AND DISCUSSIONS 
4.1 Analytical Measurement Method Development 
4.1.1 Solid phase extraction 
Since Oasis HLB cartridge consists of a hydrophilic-lipophilic balanced adsorbent, it 
is quite capable of adsorbing compounds having different polarities.  However, 
elution of adsorbed compounds seems to be problematic.  Different solvents having 
different polarities were used in SPE procedure in order to tackle this problem.  
To efficiently elute less polar compounds such as hormones solvents less polar than 
acetonitrile and methanol was used.  Although dichloromethane with methanol did 
not provide good recoveries, MTBE with methanol was essential to achieve high 
recoveries for hormones.  On the other hand, these two solvents were not enough to 
efficiently elute other compounds in particular antibiotics.  Therefore, acetonitrile 
and acetone were added to SPE elution step. 
All recoveries were between 60 and 119 % (Table 4.1).  While caffeine and naproxen 
had excellent recoveries, antibiotics, and E1 had fair recoveries.  Generally, 
recoveries in ultra-pure water were better than recoveries in river water.  This is due 
to matrix effect which is the main drawback of ESI. 
Drying time of elution may also affect recoveries.  Since none of the target 
compounds are volatile, evaporation until dryness and hence long evaporation times 
(~1.5 hour) does not cause any adverse effect.  
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Table 4.1: Recoveries of the compounds. 
Compound 
Recovery, % (RSD, %) 
Ultra-pure water River water 
10 ng/L 100 ng/L 10 ng/L 100 ng/L 
β-Blockers     
Atenolol 94 (7.3) 98 (6.7) 80 (11.2) 85 (10.7) 
Propranolol 88 (10.3) 91 (9.6) 71 (14.9) 77 (13.5) 
Antibiotics     
Amoxicillin 72 (12.5) 77 (12.7) 61 (13.5) 67 (13.4) 
Ciprofloxacin 87 (9.3) 104 (6.7) 64 (10.2) 75 (9.9) 
Erythromycin 73 (9.2) 79 (9.2) 61 (13.4) 66 (12.6) 
Sulfamthoxazole 85 (10.2) 92 (9.8) 75 (11.9) 78 (11.2) 
NSAIDs     
Diclofenac 88 (9.3) 93 (8.8) 72 (12.2) 86 (11.4) 
Ibuprofen 97 (7.3) 99 (6.9) 67 (11.1) 73 (10.3) 
Naproxen 98 (7.5) 99 (7.2) 93 (8.3) 95 (8.1) 
Hormones     
E1 81 (9.4) 86 (9.1) 63 (14.3) 76 (13.1) 
E2 96 (9.1) 105 (8.5) 71 (13.2) 85 (11.9) 
E3 96 (8.9) 119 (8.1) 81 (10.7) 93 (10.1) 
EE2 92 (9.6) 94 (9.2) 84 (10.6) 90 (9.9) 
Stimulant     
Caffeine 99 (7.1) 99 (6.5) 96 (8.4) 98 (7.9) 
4.1.2 LC-MS/MS analysis 
Acetonitrile was selected as the organic solvent in this method, because higher 
sensitivities were achieved for hormones with acetonitrile rather than methanol.  
Some studies indicate that NH4OH enhances ionization during NI mode detection 
(Kasprzyk-Hordern et al., 2008a; Yamamoto et al., 2006).  The enhancement of 
signal intensity depends on the concentration of mobile phase additive.  While low 
concentrations of mobile phase additive may not be enough to enhance the signal 
intensity, high concentrations cause decreases in signal intensity.  Different NH4OH 
concentrations were evaluated in order to determine the optimum NH4OH 
concentration and it was determined as 10 mM (Figure 4.1).  Previous studies 
suggest addition of either formic or acetic acids to promote positive ionization of 
compounds.  In this study, formic acid which provided good chromatographic 
separation, sensitivity, and peak shape was used (Figure 4.2).  
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Figure 4.1: An example of chromatograms in negative ionization mode. 
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0
Time (min)
0
50
100
0
50
100
0
50
100
0
50
100
Ibuprofen (205.4 => 161.4)
d3-Ibuprofen (208.2 => 164.2) 
Naproxen (229.3 => 170.1)
Diclofenac (294 => 249.9)
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0
Time (min)
0
50
100
0
50
100
0
50
100
0
50
100
0
50
100
0
50
100 E1 (269 =>  145.1)
E2 (271.1 =>  182.96)
d2-E2 (273 =>  147.2)
E3 (287 =>  170.87)
EE2 (295 =>  145.1)
2C13-EE2 (297 =>  159)
 58 
 
 
Figure 4.2: An example of chromatograms in positive ionization mode. 
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ionized well enough during reversed phase chromatography.  To prevent this 
problem, three lines of LC system were used.  One mobile phase line was dedicated 
to ultra-pure water with additive and the percentage of this solution was not changed 
during the whole run.  Based on the results of preliminary trials, sensitivity, 
particularly for the compounds leaving column towards the end of the run were 
higher than in two-line system. 
Protonated and deprotonated ions were used for all MS/MS transitions of PI and NI 
modes, respectively.  Intensity of ionization varied among compounds due to 
existence of different functional groups in molecular structures.  Caffeine, naproxen, 
and diclofenac had highest intensities.  Although the lowest intensities among the 
compounds were achieved for the hormones, the MQLs were still as low as 1 ng/L 
for all of the hormones. 
Two peaks were observed for erythromycin which is parallel to other studies in 
literature (Vanderford et al., 2003).  The highest peak was used for quantification 
(Figure 4.2). 
4.1.3 Quality assurance/Quality control 
In order to determine signal suppression due to sample matrix, areas of the peaks of 
the compounds in spiked ultra-pure water and spiked samples were compared.  The 
highest signal suppression, more than 60%, was observed for diclofenac, naproxen 
and E3.  Signal suppressions for erythromycin, sulfamethoxazole, E1, and caffeine 
were fairly low (<20%).  To eliminate quantification errors due to signal suppression 
methods such as sample extract dilution (Gros et al., 2006), standard addition and 
internal standard calibration can be used.  Among these methods, calibration with 
internal standard that is chemically similar to the analyte or the isotopically labelled 
form of the analyte is the most commonly used technique for quantification of 
pharmaceuticals and hormones in environmental waters, because it is less time 
consuming than other methods.  Since isotopically labelled standards are not 
commercially available for all compounds and existing ones are very expensive, it is 
not possible to use internal standards for all compounds.  As a matter of fact, the lack 
of compound-specific internal standards is the main limitation for analysis of 
pharmaceuticals and hormones in environmental matrices (Gros et al., 2009; 
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Kasprzyk-Hordern et al., 2008b).  The suitability of internal/surrogate standards was 
evaluated whether they can prevent quantification errors due to ion suppression.  
Method detection limit (MDL) and method quantification limit (MQL) were 
estimated from sample injections where signal-to-noise ratios of 3 and 10, 
respectively.  Since MDL and MQL were slightly different in different sample 
matrices, averages were calculated in order to report one figure for each.  Instrument 
detection limit (IDL) was determined via injection of series of dilutions of standards 
until to a signal-to-noise ratio of 3.  For the compounds tested, IDL, MDL and MQL 
were in the range of 0.1-12.25 pg, 0.1-0.5 ng/L and 0.5-1.3 ng/L, respectively.  While 
highest sensitivities were achieved for atenolol and diclofenac (MQL=0.5 ng/L) the 
method had lowest sensitivity for propranolol (MQL=1.3ng/L).  Results of SPE 
recoveries, IDL, MDL, MQL and signal suppressions are provided in Table 4.2.   
Table 4.2: Instrumental/method detection limits, method quantification limit and 
signal suppression. 
Compound IDL (pg) MDL (ng/L) MQL (ng/L) 
Signal 
suppression 
(%) 
β-Blockers     
Atenolol 2.5 0.25 0.5 31 
Propranolol 6.25 0.5 1.3 39 
Antibiotics     
Amoxicillin 12.5 1 1.5 32 
Ciprofloxacin 1 0.1 1 23 
Erythromycin 0.25 0.2 0.7 17 
Sulfamethoxazole 0.625 0.1 1 16 
NSAIDs     
Diclofenac 0.125 0.1 0.5 67 
Ibuprofen 1.25 0.2 1.1 54 
Naproxen 0.1 0.2 0.9 63 
Hormones     
E1 0.625 0.5 1 17 
E2 1.5 0.5 1 41 
E3 2.5 0.5 1 67 
EE2 2.5 0.5 1 54 
Stimulant     
Caffeine 6.25 0.5 1 15 
50 µg/L of a standard mixture were injected 5 times per day in different days in order 
to calculate repeatability and reproducibility.  Relative standard deviations (RSDs) of 
repeatability and reproducibility tests were lower than 9% and 17%, respectively. 
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Calibration curves were estimated as linear curves using 1/x weighing least square 
regression.  Each calibration curve had at least 0.99 R2 value.  Concentration range of 
calibration curves were 1-100 µg/L which yields 1-100 ng/L concentration rage after 
a concentration factor of 1000 by SPE.  7 point-internal standard calibration was 
used for quantification.  Standards were injected three times in each run scattered 
throughout whole run to prevent errors caused by possible fluctuations. 
4.2 Occurrence of the Pharmaceuticals and Hormones 
Measurement results of samples taken in February are provided in Table 4.3.  
Table 4.3: Concentrations of pharmaceuticals and hormones in February. 
 Lake Karasu Tahtakoprü Hamza Ahlat Beylikçayı
Antibiotics       
Amoxicillin BQL 10.10 4.80 BQL 48.10 9.20 
Ciprofloxacin 11.50 BDL 4.40 4.50 44.50 BDL 
Erythromycin 0.70 1.60 1.00 0.90 7.90 BQL 
Sulfamethoxazole BQL 6.30 4.50 2.60 9.90 4.30 
β-Blockers       
Atenolol 4.70 2.40 4.00 1.20 20.20 BDL 
Propranolol BDL BDL BDL BDL BDL BDL 
Hormones       
E1 BDL 1.10 BQL BQL BDL BQL 
E2 1.10 BDL BDL BDL BDL 1.10 
E3 4.60 3.10 3.70 1.90 4.00 3.40 
EE2 BDL BDL BDL BDL BDL BDL 
NSAIDs       
Diclofenac 1.70 1.20 5.30 8.30 8.10 1.80 
Ibuprofen 29.10 BDL BDL 14.20 BDL 108 
Naproxen 8.30 75.20 88.60 129 2.60 411 
Stimulant       
Caffeine 32.60 1290 46.80 21.40 46.70 5525 
All concentrations are in ng/L 
BDL: Below Detection Limit 
BQL: Below Quantification Limit 
Caffeine concentrations over μg/L level in Karasu and Beylikçayı indicate 
wastewater contamination in these tributaries.  The most polluted tributary was 
Beylikçayı in this sampling term with high caffeine, ibuprofen, and naproxen 
concentrations.  Another factor caused these high concentrations in Beylikçayı was 
low flow rate respect to other tributaries.  Another small tributary, Ahlat, had highest 
antibiotic concentrations among all sampling points in this sampling period.  On the 
other hand the greatest river in the watershed, Karasu, had relatively high naproxen 
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and caffeine concentrations meaning loads of these compounds were also high.  
Concentrations in the lake were generally lower than its tributaries.  Still, relatively 
high concentrations were observed for ciprofloxacin, ibuprofen, E3, and caffeine.  
Main source of amoxicillin and ciprofloxacin was Ahlat.  Both of the antibiotics flow 
into the lake nearly the same concentration from Ahlat.  Moreover, amoxicillin was 
measured 10.10 ng/L and 9.20 ng/L in Karasu and Beylikçayı, respectively, but 
ciprofloxacin was not detected in those rivers.  It can be considered that volume of 
the lake is that higher to neglect volumes of the tributaries flowing into the lake.  
Therefore, it would have been expected that concentration of amoxicillin in the lake 
would be higher than concentration of ciprofloxacin.  However, while ciprofloxacin 
was measured 11.50 ng/L amoxicillin concentration was below quantification limit in 
the lake.  These results indicate that amoxicillin is prone to sink processes in the 
environment and ciprofloxacin more resistant to natural removal than amoxicillin.  
Measurement results of samples taken in March are provided in Table 4.4.  
Table 4.4: Concentrations of pharmaceuticals and hormones in March. 
 Lake Karasu Tahtakoprü Hamza Ahlat 
Antibiotics      
Amoxicillin 4 21.4 7.9 9.1 40.6 
Ciprofloxacin 6.7 14.8 7.1 6.6 32.6 
Erythromycin BDL 7.1 9.7 0.9 4.2 
Sulfamethoxazole 1.5 63.9 11.2 23 15.8 
β-Blockers      
Atenolol 0.7 17.1 6.9 3.7 33.4 
Propranolol BDL BDL BDL BDL BDL 
Hormones      
E1 BQL BDL BDL BDL 1.4 
E2 1.1 1.3 BDL 1 2 
E3 2.9 3.2 1.3 1.2 6.2 
EE2 11.6 BDL BDL BDL BDL 
NSAIDs      
Diclofenac 5.5 7.8 2.9 1.2 BDL 
Ibuprofen BDL 35 50.3 13.8 112 
Naproxen 26.1 501 134 82.2 484 
Stimulant      
Caffeine 1228 50.9 953 1107 20426 
All concentrations are in ng/L 
BDL: Below Detection Limit 
BQL: Below Quantification Limit 
Sample cannot be taken from Beylikçayı in March.  The most interesting result in 
this term is approximately 20 μg/L concentration of caffeine in Ahlat.  This high 
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concentration indicates wastewater domination in Ahlat in this sampling term.  While 
approximately 1 μg/L caffeine concentration was measured in the Lake, Tahtakoprü, 
and Ahlat, 51 ng/L caffeine was measured in Karasu which was in contrast to the 
results of samples taken in February.  High caffeine concentration in the Lake 
indicates not only concentrations but also loads of caffeine were high.  Ahlat was the 
most polluted tributary in this sampling term with highest concentrations for all of 
the compounds except erythromycin, EE2, and naproxen.   
Measurement results of samples taken in May are provided in Table 4.5. 
Table 4.5: Concentrations of pharmaceuticals and hormones in May. 
 Lake Karasu Tahtakoprü Hamza Ahlat Beylikçayı
Antibiotics       
Amoxicillin BQL 23.5 14.2 15.4 6.4 2.8 
Ciprofloxacin BDL 10 4.3 8.4 35.1 10.6 
Erythromycin BQL 2.6 3.3 20.2 2 1.7 
Sulfamethoxazole 1.4 9.3 7.1 12.1 6.7 3.5 
β-Blockers       
Atenolol BDL 2.3 9.6 8.5 BDL BDL 
Propranolol BDL BDL BDL BDL BDL BDL 
Hormones       
E1 BDL BDL BDL BDL BDL BDL 
E2 BDL 1 1.2 BDL BDL 1 
E3 4.8 2.2 3.2 2.4 4.2 3.9 
EE2 BDL BDL BDL BDL BDL BDL 
NSAIDs       
Diclofenac 5.3 5.6 1.4 6.5 7.2 3.7 
Ibuprofen BDL 53.3 147.5 116.6 BDL BDL 
Naproxen 12.1 219 233 473 394 337 
Stimulant       
Caffeine 1692 1424 687 354 2035 33.2 
All concentrations are in ng/L 
BDL: Below Detection Limit 
BQL: Below Quantification Limit 
NSAIDs and Caffeine had the highest concentrations among other compounds in this 
sampling term.  All pharmaceuticals and hormones except caffeine reached their 
lowest levels in the lake due to the precipitations.  Even though there was vast 
amount of dilution due to precipitations, caffeine concentrations were still observed 
at high concentrations except Beylikçayı.  These results confirm high caffeine loads 
flowing into the lake and the rivers. 
Measurement results of samples taken in July are provided in Table 4.6. 
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Table 4.6: Concentrations of pharmaceuticals and hormones in July. 
 Lake Karasu Tahtakoprü Hamza Ahlat Beylikçayı 
Antibiotics       
Amoxicillin 1.82 3.9 1.1 8.4 1654 18.4 
Ciprofloxacin 822 322 207 1537 13567 3580 
Erythromycin 10.4 16.3 12.9 21.1 131 56.8 
Sulfamethoxazole 5.7 38.0 56.4 332 31.4 229 
β-Blockers       
Atenolol BDL 30.1 11.7 BDL 122.3 83.1 
Propranolol 129 160 90.4 561 66.5 BDL 
Hormones       
E1 5.7 6.0 6.0 BDL BDL BDL 
E2 10.2 9.9 BDL 9.8 BDL 10.2 
E3 BDL BDL BDL BDL BDL BDL 
EE2 11.7 13.0 BDL BDL BDL 14.0 
NSAIDs       
Diclofenac BDL 12.3 BDL 7.0 2.5 30.7 
Ibuprofen BDL 96.1 BDL BDL 26.7 111 
Naproxen BDL 401 184 203 1298 12300 
Stimulant       
Caffeine 1793 256 1446 328 5435 47.8 
All concentrations are in ng/L 
BDL: Below Detection Limit 
BQL: Below Quantification Limit 
Highest concentrations of almost all compounds were observed in this sampling term 
due to dry weather conditions.  Ciprofloxacin concentrations in Ahlat and Beylikçayı 
were close to concentrations measured in hospital effluents (Seifrtova et al., 2008; 
Verlicchi et al., 2010).  Amoxicillin concentration in Ahlat was also unexpectedly 
high.  Higher values, respect to other sampling terms, of erythromycin and 
sulfamethoxazole were observed in July.  E1, E2, and EE2 had 50% detection 
frequency with higher concentrations respect to other sampling terms.  On the other 
hand, E3 was not detected in July that all of the other sampling terms it was 
conversely detected in all sampling points.  Naproxen concentrations in Ahlat and 
Beylikçayı are typical wastewater concentrations (Camacho-Munoz et al., 2010; Jelic 
et al., 2011).  It can easily be said that Ahlat and Beylikçayı were the most polluted 
and wastewater dominated streams with concentrations found typically in 
wastewaters in this sampling term.  High ciprofloxacin and caffeine concentrations in 
the lake indicate high ciprofloxacin and caffeine load flowing into the lake.  
Measurement results of samples taken in October are provided in Table 4.7. 
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Table 4.7: Concentrations of pharmaceuticals and hormones in October. 
 Lake Karasu Tahtakoprü Hamza Ahlat Beylikçayı
Antibiotics       
Amoxicillin BDL 63.9 BDL 57.3 30.3 33.6 
Ciprofloxacin 49.3 191 65.3 416 141 110 
Erythromycin 1.8 31.4 4.1 6.9 3.7 11.3 
Sulfamethoxazole 3.6 85.5 10.9 63.4 10.3 98.9 
β-Blockers       
Atenolol BDL 54.8 9.2 BDL 7.8 13.9 
Propranolol 71.6 137 30.5 BDL BDL 19.3 
Hormones       
E1 BDL BDL 1.92 BDL BDL BDL 
E2 1.73 BDL BDL BDL BDL BDL 
E3 11.3 9.8 BDL 16 8.8 BDL 
EE2 BDL BDL BDL BDL BDL BDL 
NSAIDs       
Diclofenac 52 45.7 34.7 BDL BDL BDL 
Ibuprofen 238 209 182 215 263 136 
Naproxen 1.4 102 51.1 34.1 28.6 88.3 
Stimulant       
Caffeine 442 4160 1257 576 421 4800 
All concentrations are in ng/L 
BDL: Below Detection Limit 
BQL: Below Quantification Limit 
Dramatic effects of dry weather conditions were decreased in this term.  Still, higher 
concentrations than winter and spring sampling terms were observed.  High 
ibuprofen concentrations may be due to high usage rates of this pharmaceutical in 
this time of the year.  Hormone levels returned to its condition before summer with 
low detection rates for E1, E2, and EE2 and high detection rates for E3.  Caffeine 
concentration in the lake was at the lowest state which is sign of decrease in caffeine 
loads.  
Median, maximum concentrations and frequency of quantifications in the lake and its 
tributaries were provided in Table 4.8. 
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Table 4.8: Median, maximum concentrations and frequency of quantification of the compounds. 
 Lake Karasu Tahtakoprü Hamza Ahlat Beylikçayı 
 #1 max median2 #1 max median2 #1 max median2 #1 max median2 #1 max median2 #1 max median2 
Antibiotics                   
Amoxicillin 40 4.00 2.91 100 63.9 21.4 80 14.2 6.35 80 57.3 12.3 100 1654 40.6 100 33.6 13.8 
Ciprofloxacin 80 822 30.4 80 322 102.9 100 207 7.1 100 1537 8.40 100 13567 44.5 75 3580 110 
Erythromycin 60 10.4 1.80 100 31.4 7.1 100 12.9 4.1 100 21.1 6.90 100 131 4.20 75 56.8 11.3 
Sulfamethoxazole 80 5.73 2.55 100 85.5 37.98 100 56.4 10.9 100 332 23 100 31.4 10.3 100 229 51.6 
β-Blockers                   
Atenolol 40 4.70 2.70 100 54.8 17.1 100 11.7 9.20 60 8.50 3.70 80 122 26.8 50 83.1 48.5 
Propranolol 40 129 100 40 160 148 40 90.4 60.4 20 561 561 20 66.5 66.5 25 19.3 19.3 
Hormones               
E1 20 5.74 5.74 40 6.04 3.57 40 6.01 3.97 0 0 0 20 1.40 1.40 0 0 0 
E2 80 10.2 1.42 60 9.9 1.30 20 1.20 1.20 40 9.78 5.39 20 2.00 2.00 75 10.2 1.10 
E3 80 11.3 4.70 80 9.85 3.15 60 3.70 3.20 80 16.0 2.15 80 8.84 5.20 50 3.90 3.65 
EE2 40 11.7 11.65 20 13.1 13.1 0 0 0 0 0 0 0 0 0 25 14.0 14.0 
NSAIDs                    
Diclofenac 80 52.0 5.40 100 45.7 7.80 80 34.7 4.10 80 8.30 6.74 60 8.10 7.20 75 30.7 3.70 
Ibuprofen 40 238 134 80 209 74.7 60 182 148 80 215 65.4 60 263 113 75 136 111 
Naproxen 80 26.1 10.2 100 502 219 100 233 135 100 473 129 100 1298 394 100 12300 374 
Stimulant               
Caffeine 100 1793 1228 100 4160 1290 100 1446 954 100 1107 354 100 20427 2035 100 5525 2424 
All concentrations are in ng/L.  
1Quantification frequency (%) 
2Median concentration of positive results 
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Caffeine and sulfamethoxazole were detected in all of the samples.  Amoxicillin, 
ciprofloxacin, erythromycin, atenolol, E3, diclofenac, ibuprofen, and naproxen were 
detected in most of the samples.  EE2 was the least detected compound.  Caffeine 
had the highest median and maximum concentrations.  Since caffeine in 
environmental samples is an indicator for wastewater pollution (Guo and Krasner, 
2009), all rivers and lake are thought to have been polluted by wastewater. Highest 
concentrations of caffeine, ciprofloxacin, and naproxen were observed at µg/L levels.  
The concentrations of all hormones exceeded the endocrine disrupting level of 1 
ng/L (Routledge and Sumpter, 1996) at least once and mostly more than once. 
All antibiotics were detected in most of the samples.  In most cases, amoxicillin 
concentrations were higher than other antibiotics which is expected since excretion 
rate of amoxicillin is between 80-90% (Jjemba, 2006).  However, this is not valid for 
samples taken in July. Ciprofloxacin concentrations were higher than amoxicillin in 
all sampling points and sulfamethoxazole and erythromycin concentrations were 
higher than amoxicillin in the lake, Karasu, Tahtakoprü and Hamza Rivers in July.  
Amoxicillin’s photodegradability (Mavronikola et al., 2009) and other antibiotics’ 
persistency may have caused this result during dry weather conditions.  In spite of 
photodegradability of amoxicillin, high detection indicates high discharge of it.  
Ciprofloxacin concentrations were unexpectedly high (few µg/L) and close to levels 
observed in hospital effluents (Seifrtova et al., 2008; Verlicchi et al., 2010), in Ahlat, 
Beylikçayı Creeks, and Hamza River in June.  Amoxicillin, erythromycin, and 
sulfamethoxazole concentrations were in range similar to previous studies. 
Detection frequency of propranolol was very low since excretion rate of propranolol 
as an unchanged product is below 1%.  Nevertheless, propranolol was measured as 
high as 561 ng/L in dry weather conditions.  Atenolol was determined in every 
sampling period as expected from its high usage and about 90% excretion rate as an 
unchanged compound (Zuccato et al., 2005).  Atenolol and propranolol 
concentrations were similar to previous studies (Bendz et al., 2005; Vieno et al., 
2006; Zuccato et al., 2005).   
There are conversion mechanisms among E1, E2, and E3.  E1 is favored in these 
mechanisms.  However, adsorption rate of E1 to sediments is higher than E2.  It is 
theorized that E2 was converted to E1 meanwhile some of E1 was adsorbed to 
sediment, some of it converted E3.  Therefore, E2 and E3 were the highest detected 
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compounds among hormones (60% in average) and EE2 and E1 were detected only 
four and six times in 29 samples, respectively.  These results confirm lab scale 
studies found that E1 and EE2 are more easily removed from aqueous phase than E2 
and E3 in field scale.  However, it is not valid for sample taken in June with 
detection of E3 neither of the sampling points.  This may be caused by exposure of 
UV susceptible hormones to higher UV radiation and going under high rate of 
degradation.  Although EE2 is more stable and persistent than natural hormones, low 
detection frequency reflects low usage rate of this compound.  Even though all 
hormone concentrations were very close to the quantification limit, these 
concentrations are high enough to induce endocrine disruption in aquatic species in 
the watershed.  Moreover, since concentrations of some hormones in Büyükçekmece 
Lake, which is an important drinking water source for Istanbul, have reached levels 
as high as 11.7 ng/L, hormones may pose a threat to human health. 
Diclofenac concentrations were in the similar range with previous occurrence studies 
in surface waters.  Ibuprofen concentrations were similar to studies conducted in 
Luxemburg and South Korea, but higher than in UK, Italy and USA.  Naproxen 
generally had highest concentrations among NSAIDs as generally observed in the 
literature (Fernandez et al., 2010; Hernando et al., 2006; Hilton and Thomas, 2003; 
Kasprzyk-Hordern et al., 2008c; Kim et al., 2007a; Pailler et al., 2009; Weigel et al., 
2004).  On the other hand, in July naproxen concentrations were 1.3 µg/L and 12.3 
µg/L in Ahlat and Beylikçayı Creeks, respectively similar to concentrations observed 
in wastewater (Camacho-Munoz et al., 2010; Jelic et al., 2011).  
The maximum concentrations were observed in July and October.  The difference 
between wet weather conditions (winter/spring) and dry weather conditions 
(summer/fall) was one or two orders of magnitude.  Since there were not enough 
positive results for hormones in order to explain seasonal variations, seasonal 
changes in median concentrations of only pharmaceuticals were provided in  
Figure 4.3. 
Highest median concentrations for all pharmaceuticals were measured either in July 
or October except for caffeine.  Most dramatic increases in concentrations during dry 
weather conditions were observed for ciprofloxacin, propranolol, atenolol, and 
sulfamethoxazole.  The increase in these concentrations in summer sampling period 
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indicates that wastewater discharges dominate streams during this period.  In 
particular, small streams like Ahlat and Beylikçayı Creeks were affected more from 
wastewater domination.  
 
Figure 4.3: Seasonal variations in median concentrations. 
Pharmaceutical and water usage rates differ from country to country and even among 
different communities in a country.  However, it is not possible to predict 
environmental concentrations of PPCPs from usage rates due to the fact that different 
environmental conditions in a watershed will affect the fate of these compounds. 
Therefore, the concentrations of pharmaceuticals and hormones must be monitored 
on a watershed basis.  
4.3 Ecotoxicological Test Results 
The two sets of data are collected based on ecotoxicological tests on single 
compounds and ecotoxicological tests on mixtures of compounds within the 
therapeutic groups.  Mixtures of the compounds according to the therapeutic groups 
were prepared to determine their effect when they are in mixture.  Concentrations of 
compounds used in the mixture were selected based on their single toxicity results 
and serial dilutions were prepared.  Some pharmaceuticals and hormones did not 
exhibit any effect at water soluble (bioavailable) concentrations in particular in D. 
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magna immobilization test.  These compounds were not included in the mixtures to 
be able to correctly predict the possible additive/synergistic effect. 
To figure out the interactions of the compounds, the measured effects of these 
concentrations in the mixtures were compared with the effect of the same 
concentrations of each compound when they are single in a solution.  The sum of 
singular effects of each compound in the mixture was predicted with a model.  
According to the model, to calculate the sum of singular effects in the mixture the 
equation below was used.  
෍ܧܥ	ܿ௜
௡
௜ୀଵ
 
where “ci” represents the individual concentrations of the single substances present in 
a mixture, and “EC ci” are the effects of single substances that would alone cause at 
the concentration “ci”.  According to this equation, result should be equal to the 
measured effect assuming additive response.  Consequently, two data sets consisting 
of the measured and the predicted effects were compared.  While results smaller than 
the measured effect indicate synergistic interaction of the compounds, antagonistic 
interaction causes a result higher than the measured effect.  
4.3.1 D. magna acute immobilization test results 
Before single compound tests, the range of the working solution concentrations was 
determined in the light of literature values.  The ranges were selected narrow enough 
to establish a reliable non-linear regression and wide enough to cover certain 
endpoints such as EC50. 
Acute immobilization test results were main data used to select chronic test 
concentration ranges.   
Among antibiotics, ciprofloxacin triggered no acute effect on D. magna in the range 
of bioavailable concentrations (<10 mg/L).  Other studied antibiotics are more 
soluble in water.  Therefore, their acute immobilization tests were conducted (Figure 
4.4). 
(4.1) 
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Figure 4.4: Regression curves of antibiotics for immobilization of D. magna in 48h. 
Although all concentrations studied for acute effects of antibiotics to D. magna were 
much higher than environmental concentrations, this test shows trends of the effects 
of antibiotics.  EC50 values were 113 mg/L, 189 mg/L, and 95 mg/L for amoxicillin, 
erythromycin and sulfamethoxazole.  Although gap between curves of amoxicillin 
and erythromycin increases with increasing concentrations, they have similar effects 
at concentrations lower than 50 mg/L.  Shape of the curve of sulfamethoxazole and 
consequently effect trend is different from of which erythromycin and 
sulfamethoxazole since while 3 parameter logistic non-linear regression was used for 
sulfamethoxazole 4 parameter sigmoid non-linear regression was used for others.  
Sulfamethoxazole had the highest effects at concentrations below 125 mg/L which is 
unlikely to find in environmental waters.   
A mixture of these three antibiotics was prepared to determine their effect when they 
are in mixture.  Concentrations in mixture were prepared according to acute toxicity 
results with an assumption that they will have additive interaction when they are in 
mixture and serial dilutions were prepared (Table 4.9).   
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Table 4.9:  Concentrations of antibiotics in mixture for D. magna immobilization 
test. 
Concentration Level Amoxicillin Erythromycin Sulfamethoxazole 
1 6 15 9 
2 12 31 18 
3 25 62 36 
4 50 125 73 
All concentrations are in mg/L 
The 3 parameter sigmoidal estimations of predicted and measured curves were 
provided in Figure 4.5. 
 
Figure 4.5: Measured and predicted curves for antibiotic mix for D. magna 
immobilization test. 
The main finding is antibiotics interact synergistically when they are in mixture.  The 
differences between measured and predicted effects are limited until concentration 
level 3.  After that, the gap between the effects increases indicating synergistic 
interaction increases.   
Atenolol and propranolol are the β-blockers that were tested (Figure 4.6). 
Concentration Level
1 2 3 4
Im
m
ob
ili
za
tio
n 
(%
)
0
20
40
60
80
100
Measured Effect 
Amoxicillin 
Erythromycin 
Sulfamethoxazole 
 73 
 
 
Figure 4.6: Regression curves of β-blockers for immobilization of D. magna in 48h. 
Even though atenolol and propranolol belong to same therapeutic group, their acute 
impacts to D. magna are very different.  While EC50 of atenolol was 185 mg/L, 
propranolol had 3.3 mg/L.  Atenolol and propranolol had 32 mg/L and 1.24 mg/L 
NOECs, respectively.  While atenolol had 295 mg/L EC80 value it was 5.6 mg/L for 
propranolol.  4 parameter sigmoid regression for atenolol and 3 parameter logistic 
regression for propranolol were used to estimate concentration response curves.  
Although concentration ranges are as different as one order of magnitude, 
concentration response curves of both atenolol and propranolol have similar shapes.  
This indicates that these two compounds have similar effect trends to acute 
immobilization of D. magna.  Similar EC50 values were reported in previous studies 
for both atenolol and propranolol (Cleuvers, 2003; 2005; Huggett et al., 2002). 
A binary mixture of two β-blockers was prepared to determine their effect when they 
are in mixture.  Concentrations in mixture were prepared according to acute toxicity 
results with an assumption that they will have additive interaction when they are in 
mixture and serial dilutions were prepared (Table 4.9).   
Concentration (mg/L)
0 2 4 6 8 200 400 600
Im
m
ob
ili
za
tio
n 
(%
)
0
20
40
60
80
100
Atenolol
Propranolol
 74 
 
Table 4.10: Concentrations of β-blockers in mixture for D. magna immobilization 
test. 
Concentration Level Atenolol Propranolol 
1 16 0.62 
2 32 1.24 
3 65 2.5 
4 130 5 
All concentrations are in mg/L. 
 
Figure 4.7: Measured and predicted curves for β-blockers mix for D. magna 
immobilization test 
The most interesting result for β-blocker mix test was at concentration level 2.  At 
concentration level 1 no effect was observed in mixture as predicted from single 
effects of the compounds.  Even though NOECs of two compounds mixed at 
concentration level 2, 10% immobilization observed.  This situation was just a 
simple example for presenting how interaction between chemicals may cause drastic 
and unexpected effects to living organisms.  In all points, synergistic interactions 
were observed.   
Naproxen presented no acute effect at bioavailable concentrations to D. magna in 
48h.  Therefore, only for diclofenac and ibuprofen regression curves were estimated 
as 3 parameter sigmoid and 3 parameter logistic, respectively (Figure 4.8).  
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Figure 4.8: Regression curves of NSAIDs for immobilization of D. magna in 48h. 
Ibuprofen had higher acute effects to D. magna than Diclofenac.  EC 50 values were 
55 mg/L and 1.8 mg/L for diclofenac and ibuprofen, respectively.  Ibuprofen’s 
accelerated increase results 7.2 mg/L EC80 value.  EC80 for diclofenac was 10 times 
higher (72 mg/L).  NOECs were 4.5 mg/L and 0.35 mg/L for diclofenac and 
ibuprofen, respectively.  Accelerated increase of ibuprofen concentration response 
curve results in narrow range between NOEC and EC80 (7 mg/L).  It is contrary for 
diclofenac with a 68 mg/L range between NOEC and EC80.  Different EC50 values 
(in 22 mg/L – 108 mg/L range) were reported in different studies for diclofenac in 
the literature (Cleuvers, 2003; Cleuvers, 2004).  The EC50 value found in this study 
is in this range.  However higher EC50 values were reported for ibuprofen from 10 to 
100 mg/L (Heckmann et al., 2007). 
A binary mixture of diclofenac and ibuprofen and series of dilutions of this mixture 
were prepared according to single toxicity results (Table 4.11). 
Table 4.11: Concentrations of NSAIDs in mixture for D. magna immobilization test. 
Concentration Level Diclofenac Ibuprofen 
1 4.5 0.35 
2 9 0.7 
3 18 1.4 
4 36 3.3 
5 72 6.6 
All concentrations are in mg/L. 
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Comparison between predicted and measured results for mixture toxicity was 
provided in Figure 4.9. 
 
Figure 4.9: Measured and predicted effects of NSAID mixture to immobilization of 
D. magna. 
Measured effect bars represent immobilization of D. magna at all concentration 
levels with standard deviation as error bars.  Stacked bars represent predicted effects 
of single compounds in the mixture.  At concentration levels 1-3 synergistic 
interactions were observed.  Although, at concentration level 4, it seems that there is 
a synergistic interaction, residual is close to zero.  The gap between measured and 
predicted effects remains nearly the same at concentration level 1 to 4.  At 
concentration level 5, predicted immobilization was higher than 100% which yielded 
100% immobilization in the real case.  Diclofenac’s contribution to predicted effect 
remained at low levels for the first three concentration levels since diclofenac’s 
single toxicity regression curve has exponential increase shape until 40 mg/L. 
EC50 of caffeine for this test was 206 mg/L (Figure 4.10).  NOEC of caffeine was 50 
mg/L which is unlikely to be found in environmental waters.  
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Figure 4.10: Regression curve of caffeine for immobilization of D. magna in 48h. 
None of the hormones caused immobilization enough to calculate EC endpoints and 
estimate concentration response curves to D. magna at bioavailable concentrations.  
However, low level immobilizations (<15%) were observed.  Therefore, NOECs 
were calculated as 0.5 mg/L, 0.25 mg/L, 0.16 mg/L and 1 mg/L for E1, E2, E3, and 
EE2, respectively.   
4.3.2 Freshwater algae growth inhibition test results 
P. subcapitata are widely used test organisms to determine ecotoxicological effects 
of chemicals.  They are also widely found in freshwater all over the world.  
Therefore, ecotoxicological data obtained from this test applicable to most of the 
areas.  Since P. subcapitata are primary producers, any effect to them would directly 
affect whole food web.  Moreover, their sensitive nature makes them great test 
species for ecotoxicological bioassays. 
All antibiotics were tested in concentration ranges wide enough to cover endpoints 
and narrow enough to achieve robust non-linear regression estimations (Figure 4.11). 
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Figure 4.11: Regression curves of antibiotics for freshwater algae test. 
Erythromycin had highest impact with 0.11 mg/L, 0.15 mg/L and 0.014 mg/L EC50, 
EC80, and NOEC values.  After erythromycin, sulfamethoxazole comes with 0.72 
mg/L EC50 and 0.05 mg/L NOEC.  Unlike D. magna immobilization test, there was 
positive result for ciprofloxacin with 3.4 mg/L and 0.1 mg/L EC50 and NOEC, 
respectively.  Amoxicillin triggered lowest impact to P. subcapitata with 82 mg/L 
EC50 value.  3 parameter sigmoid, 4 parameter sigmoid, 4 parameter Hill, 4 
parameter logistic non-linear regressions were used to estimate concentration-
response curves of amoxicillin, ciprofloxacin, erythromycin, and sulfamethoxazole, 
respectively.  Since all of the concentration-response curves were fit to different non-
linear regression method, trends were different for all of the compounds.  Since 
erythromycin causes growth inhibition at low concentrations, its rapidly increasing 
curve causes only 0.14 mg/L difference between NOEC and EC80.  For amoxicillin 
higher NOEC (250 mg/L) was reported in the literature (Lutzhoft et al., 1999). This 
may be caused by the photodegradability of amoxicillin.  On the other hand, similar 
EC50 and NOECs were reported for both erythromycin and sulfamethoxazole 
(Eguchi et al., 2004; Isidori et al., 2005b). 
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A mixture of amoxicillin, ciprofloxacin, erythromycin, and sulfamethoxazole and 
series of dilutions of this mixture were prepared according to single toxicity results 
(Table 4.12). 
Table 4.12: Concentrations of antibiotics in mixture for P. subcapitata growth 
inhibition tests. 
Concentration 
Level Amoxicillin Ciprofloxacin Erythromycin Sulfamethoxazole
1 5 0.1 0.014 0.05 
2 10 1 0.028 0.1 
3 20 2 0.056 0.2 
4 40 4 0.112 0.5 
All concentrations are in mg/L. 
Comparison between predicted and measured results for mixture toxicity was 
provided in Figure 4.12. 
 
Figure 4.12: Measured and predicted effects of antibiotic mixture to P. subcapitata. 
At concentration level 1, all antibiotics were mixed at concentrations triggering no 
effect when they are in mixture.  However, 10% growth inhibition was observed at 
this concentration level.  At all concentration levels, measured effects seem higher 
than predicted effects indicating studied antibiotics interact synergistically.  However, 
at concentration levels 2 and 3 the measured effects and the predicted effects are not 
statistically different. 
β-blockers, atenolol and propranolol, were tested to find growth inhibition to P. 
subcapitata (Figure 4.13). 
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Figure 4.13: Freshwater algae test results for β-blockers. 
Like D. magna immobilization test atenolol and propranolol had very different 
effects to growth inhibition of P. subcapitata with 367 mg/L and 1 mg/L EC50 
values, respectively.  While NOECs were 130 mg/L and 0.16 mg/L, EC80s were 600 
mg/L and 1.74 mg/L for atenolol and propranolol, respectively.  Both of the atenolol 
and propranolol concentration-response curves were estimated with 4 parameter 
sigmoid non-linear regression.   
A binary mixture of atenolol and propranolol and series of dilutions of this mixture 
were prepared according to single toxicity results (Table 4.13). 
Table 4.13: Concentrations of β-blockers in mixture for P. subcapitata growth 
inhibition tests. 
Concentration Level Atenolol Propranolol 
1 100 0.16 
2 200 0.31 
3 300 0.62 
4 400 1.24 
All concentrations are in mg/L. 
Comparison between predicted and measured results for mixture toxicity was 
provided in Figure 4.14. 
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Figure 4.14: Predicted and measured curves for β-blockers. 
At concentration level 1, which is prepared with β-blockers at concentrations 
creating no effects on growth inhibition of P. subcapitata, 10% inhibition was 
observed.  At all concentration levels measured effects were higher than predicted 
effects indicating synergistic interaction between β-blockers.   
Unlike D. magna immobilization test, hormones triggered adverse effects to growth 
inhibition of P. subcapitata (Figure 4.15). 
 
Figure 4.15: Freshwater algae test results for hormones. 
All of the hormones had similar effects to P. subcapitata.  Even though non-linear 
estimations for all of the compounds are not the same (4 parameter sigmoid for E1 
and E2, 3 parameter logistic for E3, and EE2), their trends are similar.  EC50s were 
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0.64 mg/L, 0.45 mg/L, 0.40 mg/L, and 0.32 mg/L for E1, E2, E3, and EE2, 
respectively.  EE2 were the most ecotoxic compound among hormones in 
concentration range until 0.6 mg/L for freshwater algae growth inhibition test.  After 
0.6 mg/L, E2 was the most ecotoxic compound.  E1 was the least ecotoxic compound 
among hormones in tested concentration ranges. NOECs were 0.03 mg/L for E1 and 
E2, 0.04 for E3 and 0.02 for EE2.   
A mixture of E1, E2, E3, and EE2 and series of dilutions of this mixture were 
prepared according to single toxicity results (Table 4.14). 
Table 4.14: Concentrations of hormones in mixture for P. subcapitata growth 
inhibition tests. 
Concentration Level E1 E2 E3 EE2 
1 30 30 40 20 
2 60 60 80 40 
3 120 120 160 80 
4 250 250 320 160 
All concentrations are in µg/L. 
Comparison between predicted and measured results for mixture toxicity was 
provided in Figure 4.16. 
 
Figure 4.16: Measured and predicted effects of hormone mixture to P. subcapitata. 
At concentration level 1, all hormones were mixed using NOECs when they are 
single.  No effects were observed at concentration level 1 as predicted.  However, at 
other concentration levels measured effects were more than predicted effects 
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indicating synergistic interaction among tested hormones at concentrations higher 
than no effect concentrations. 
Concentration-response curves for NSAIDs were estimated using 4 parameter 
sigmoid non-linear regression for diclofenac and naproxen and 4 parameter weibull 
non-linear regression for ibuprofen (Figure 4.17).  
 
Figure 4.17: Freshwater algae test results for NSAIDs. 
Among NSAIDs ibuprofen had highest impact to growth inhibition of P. subcapitata 
at concentrations higher than NOEC (0.7 mg/L) with 2.7 mg/L EC50.  Since NOEC 
of naproxen is 0.35 mg/L, impact of naproxen between 0.35 mg/L and 0.7 mg/L is 
higher than ibuprofen.  EC50 of naproxen was found 5.8 mg/L.  Rapidly increasing 
trend of concentration-response curve of ibuprofen also causes small difference 
between endpoints as well as higher impact at concentrations higher than NOEC.  
Diclofenac caused lowest impact to growth inhibition of P. subcapitata among 
NSAIDs with 2.4 mg/L NOEC and 12.5 mg/L EC50.  Trend of the concentration-
response curve of diclofenac has slower increase respect to ibuprofen and naproxen, 
yielding wider range between endpoints. EC80s were 17.1 mg/L, 7.2 mg/L, and 8.6 
mg/L for diclofenac, ibuprofen, and naproxen, respectively. 
A mixture of diclofenac, ibuprofen, and naproxen and series of dilutions of this 
mixture were prepared according to single toxicity results (Table 4.15). 
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Table 4.15: Concentrations of NSAIDs in mixture for P. subcapitata growth 
inhibition tests. 
Concentration Level Diclofenac Ibuprofen Naproxen
1 0.8 0.7 0.35 
2 2 1.9 0.9 
3 4 3.8 1.8 
4 6 5.5 2.65 
All concentrations are in mg/L. 
Comparison between predicted and measured results for mixture toxicity was 
provided in Figure 4.18. 
 
Figure 4.18: Measured and predicted effects of NSAID mixture to P. subcapitata. 
Concentration level 1 was prepared with NSAIDs at concentrations causing no effect 
to growth inhibition of P. subcapitata.  However, 10% growth inhibition was 
observed.  At all concentration levels measured effects were higher than predicted 
effects indicating synergistic interactions among NSAIDs.  Ibuprofen’s dominance 
was predicted in mixtures since it is measured the most ecotoxic compound among 
NSIADs.  Approximately 15% difference (synergy) was observed at concentration 
levels 3 and 4.  
Concentration-response curve for P. subcapitata growth inhibition test of caffeine 
was estimated using 4-parameter sigmoid non-linear regression method (Figure 4.19). 
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Figure 4.19: Freshwater algae test results for caffeine. 
EC10, EC50, and EC80 were 100 mg/L, 405 mg/L and 542 mg/L, respectively.  
These concentrations were unlikely to be found in environmental waters.   
4.3.3 D. magna reproduction inhibition test results 
D. magna reproduction inhibition test was one of the standard chronic 
ecotoxicological tests.  Although this test was generally not preferred among 
scientific community due to difficulty to implement 21-day test, it provides 
important information on chronic effects of compounds to ecosystem.   
Since this is a chronic toxicity test, concentrations used in the test are at least one 
order of magnitude lower than acute toxicity tests. 
Concentration-response curves of reproduction inhibition test were estimated using 
3-parameter sigmoid non-linear regression for amoxicillin, 4-parameter logistic non-
linear regression for ciprofloxacin, and 3-parameter logistic for erythromycin and 
sulfamethoxazole (Figure 4.20). 
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Figure 4.20: D. magna reproduction inhibition test results for antibiotics. 
Erythromycin caused highest inhibition to reproduction of D. magna with 2 µg/L 
NOEC, 45 µg/L EC50, and 180 µg/L EC80.  Moreover, rapidly increasing 
concentration-response curve of amoxicillin indicate high impacts may be caused at 
rather lower concentrations.  Curves of ciprofloxacin and sulfamethoxazole have an 
intersection at 100 µg/L.  Lower than 100 µg/L ciprofloxacin had higher impact with 
2 µg/L NOEC and 30 µg/L EC10 than sulfamethoxazole having 5 µg/L NOEC and 
50 µg/L EC10.  After 100 µg/L, sulfamethoxazole had higher impact than 
ciprofloxacin having 376 µg/L EC50.  Amoxicillin and sulfamethoxazole curves 
have an intersection close to EC50 endpoint resulting in similar EC50 values (248 
µg/L for amoxicillin and 233 µg/L for sulfamethoxazole).  However, different trends 
of the curves of amoxicillin and sulfamethoxazole indicate lower impacts of 
amoxicillin at concentrations lower than 250 µg/L, higher impacts at higher 
concentrations.  Amoxicillin had 6 µg/L NOEC and 340 µg/L EC80.  Amoxicillin 
and erythromycin had similar impacts when both of them are more than 350 µg/L. 
A mixture of amoxicillin, ciprofloxacin, erythromycin, and sulfamethoxazole and 
series of dilutions of this mixture were prepared according to single toxicity results 
(Table 4.16). 
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Table 4.16: Concentrations of antibiotics in mixture for D. magna reproduction 
inhibition tests. 
Concentration 
Level Amoxicillin Ciprofloxacin Erythromycin Sulfamethoxazole
1 2 2 2 2 
2 10 10 10 10 
3 20 20 20 20 
4 50 50 50 50 
All concentrations are in µg/L. 
Comparison between predicted and measured results for mixture effects of 
antibiotics was provided in Figure 4.21. 
 
Figure 4.21: D. magna reproduction inhibition test results for antibiotic mixtures. 
At concentration level 1, all antibiotics were mixed at concentrations having no 
effect to reproduction of D. magna.  However, 10% inhibition was observed.  
Moreover, all antibiotics were 2 µg/L which is quite common in wastewater and even 
in surface water, at concentration level 1.  At concentration levels 2 and 3, measured 
effects were higher than predicted effects indicating synergistic interaction.  At 
concentration level 4, the measured effect and the predicted effect were not 
statistically different indicating additive interaction.  Synergistic interaction 
decreases with increasing concentrations from 45% to approximately 0%.  These two 
findings indicate antibiotics may adversely affect ecosystem even when they are low 
µg/L concentrations.  
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Concentration-response curves for D. magna reproduction inhibition tests were 
estimated using 3-parameter sigmoid non-linear regression for atenolol and 3-
parameter logistic non-linear regression for propranolol (Figure 4.22). 
 
Figure 4.22: D. magna reproduction inhibition test results for β-blockers 
Impacts of atenolol and propranolol are significantly different for this test as well.  
Rapidly increasing curve of propranolol represents narrow range of endpoints which 
are 60 µg/L NOEC, 87 µg/L EC10, 230 µg/L EC50, and 420 µg/L EC80.  Since 
curve of atenolol has exponential type of increase, it covers rather wide concentration 
range resulting 0.6 mg/L NOEC, 1.51 mg/L EC10, 3.45 mg/L EC50, and 4.33 mg/L 
EC80.   
Atenolol and propranolol concentrations in dilutions prepared for reproduction 
inhibition test of β-blocker mixture provided in Table 4.17. 
Table 4.17: Concentrations of β-blockers in mixture for D. magna reproduction 
inhibition tests. 
Concentration Level Atenolol Propranolol 
1 20 2 
2 200 20 
3 1000 100 
4 2000 200 
5 3000 300 
All concentrations are in µg/L. 
Comparison between predicted and measured results for mixture effects of β-
blockers was provided in Figure 4.23. 
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Figure 4.23: D. magna reproduction inhibition test results for β-blocker mixtures. 
Concentration levels 1 and 2 were prepared with atenolol and propranolol at 
concentrations having no effect to reproduction of D. magna when they are single.  
At concentration level 1 no effect was detected as predicted.  However, at 
concentration level 2, 20% inhibition was measured.  Synergistic interaction 
decreases along with concentration levels having increasing concentrations as 40% 
for concentration level 3 and 29% for concentration level 4. 
Concentration-response curves were estimated using 3-parameter logistic non-linear 
regression for E1, E2, and E3 and 3-parameter sigmoid non-linear regression for EE2 
(Figure 4.24). 
Curve of E2 has the steepest shape causing narrow range between endpoints resulting 
0.5 µg/L NOEC, 10 µg/L EC10, 66 µg/L EC50, and 405 µg/L EC80.  Curve of E3 
has similar shape with curve of E2 but it gets slowly increasing after 100 µg/L.  It is 
found that NOEC is 0.2 µg/L, EC10 is 18 µg/L, EC50 is 283 µg/L for E3.  Curve of 
EE2 has similar shape with curves of E2 and E3.  However, rapidly increasing trend 
starts from relatively higher concentration as well as getting parallel to x axis.  
NOEC was 0.5 µg/L, EC10 was 17 µg/L, EC50 was 162 µg/L, and EC80 was 269 
µg/L for EE2.  E1 had lowest impact to reproduction of D. magna among hormones 
with 1 µg/L NOEC, 58 µg/L EC10, 444 µg/L EC50, and 833 µg/L EC80.   
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Figure 4.24: D. magna reproduction inhibition test results for hormones. 
A mixture of hormones and its dilutions were prepared according to single toxicity 
tests to determine mixture effects of hormones to reproduction of D. magna (Table 
4.18). 
Table 4.18: Concentrations of hormones in mixture for D. magna reproduction 
inhibition tests. 
Concentration Level E1 E2 E3 EE2 
1 0.5 0.5 0.2 0.5 
2 5 5 5 5 
3 20 20 20 20 
4 50 50 50 50 
All concentrations are in µg/L. 
Synergistic interactions were observed for hormone mixtures as well (Figure 4.25). 
At concentration level 1, each hormone was mixed using their NOECs.  It is 
predicted that no effect shod have been measured.  However, 13% inhibition 
observed which indicates synergistic interaction occurs among hormones even they 
would be at NOECs.  At concentration levels 2 and 3, 48% and 44% synergistic 
effects were observed, respectively.  At concentration level 2, synergistic effect 
seems to be 2% due to the measured effect was reached to 100%. 
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Figure 4.25: D. magna reproduction inhibition test results for hormone mixtures. 
D. magna reproduction inhibition test curves were estimated using 4-parameter 
chapman non-linear regression for diclofenac, 3-parameter sigmoid non-linear 
regression for ibuprofen and naproxen (Figure 4.26). 
 
Figure 4.26: D. magna reproduction inhibition test results for NSAIDs. 
Diclofenac was the most impacted NSAID to reproduction of D. magna until 326 
µg/L where there is an intersection between curves of diclofenac and naproxen.  
Therefore, diclofenac had lowest NOEC and EC10 values among NSAIDs as 2.6 
µg/L and 40 µg/L, respectively.  After that intersection, naproxen is NSAID having 
highest impact to reproduction of D. magna with 350 µg/L EC50 and 515 µg/L EC80.  
NOEC and EC10 of naproxen were 6 µg/L and 11.5 µg/L, respectively.  Ibuprofen 
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had the lowest impact until 567 µg/L having 8.6 µg/L NOEC, 212 µg/L EC10 and 
504 µg/L EC50 which are higher than diclofenac’s NOEC (2.6 µg/L), EC10 (40 
µg/L), and EC50 (405 µg/L).  However, that is inverted for EC80 that are 1058 µg/L 
and 775 µg/L for diclofenac and ibuprofen, respectively. 
A mixture of NSAIDs and serial dilutions for that mixture were prepared to observe 
mixture effects of NSAIDs to reproduction of D. magna (Table 4.19). 
Table 4.19: Concentrations of NSAIDs in mixture for D. magna reproduction 
inhibition tests. 
Concentration Level Diclofenac Ibuprofen Naproxen 
1 2.6 8.6 6 
2 26 86 60 
3 130 215 150 
4 260 430 300 
All concentrations are in µg/L. 
Synergistic interaction at reproduction inhibition test was observed among NSAIDs 
(Figure 4.27). 
 
Figure 4.27: D. magna reproduction inhibition test results for NSAID mixtures. 
At concentration level 1, it was predicted that no effect would have been observed 
since all NSAID in the mixture were at NOEC.  However, 25% inhibition was 
observed.  Synergistic effect decreases from 58% to 28% from concentration level 2 
to concentration level 3.  More synergistic interaction can be observed in mixture 
containing lower concentrations of NSAIDs.   
Concentration Level
1 2 3 4
In
hi
bi
tio
n 
(%
)
0
20
40
60
80
100
Measured Effects 
Diclofenac 
Ibuprofen 
Naproxen 
 93 
 
Concentration response curve for D. magna reproduction inhibition test of caffeine 
was estimated using 3-parameter logistic non-linear regression method (Figure 4.28). 
 
Figure 4.28: D. magna reproduction inhibition test results for caffeine. 
NOEC, EC10, EC50, and EC80 were 20 µg/L, 610 µg/L, 2.17 mg/L and 4.25 mg/L, 
respectively. 
All compounds were mixed to observe interactive chronic effects when they are in 
mixture.  The concentrations of the compounds in the mixture were selected in the 
light of the single compound toxicity tests (Table 4.20). 
Table 4.20: Concentrations of compounds in total mixture for D. magna 
reproduction test. 
Compounds Concentration Level 1 
Concentration 
Level 2 
Concentration 
Level 3 
Concentration 
Level 4 
Amoxicillin 0.02 0.2 1 2 
Ciprofloxacin 0.02 0.2 1 2 
Erythromycin 0.02 0.2 1 2 
Sulfamethoxazole 0.02 0.2 1 2 
Atenolol 0.04 0.4 2 4 
Propranolol 0.004 0.04 0.2 0.4 
E1 0.005 0.05 0.25 0.5 
E2 0.005 0.05 0.25 0.5 
E3 0.005 0.05 0.25 0.5 
EE2 0.005 0.05 0.25 0.5 
Diclofenac 0.026 0.26 1.3 2.6 
Ibuprofen 0.086 0.86 4.3 8.6 
Naproxen 0.06 0.6 3 6 
Caffeine 0.2 2 10 20 
All concentrations are in µg/L. 
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Concentration level 4 which contains highest concentrations was prepared with 
NOECs for each compound.  If there were no interaction among the compounds, no 
effect would have been observed at all of the concentration levels.  However, no 
effect was observed only at concentration level 1.  15%, 19%, and 23% inhibition in 
reproduction of D. magna was observed at concentration level 2, concentration level 
3, and concentration level 4, respectively.  The concentrations of the compounds in 
first two concentration levels are very common for environmental waters and 
wastewaters.  Even though the concentrations in the mixtures are below NOECs of 
the compounds, still they had impact to living organisms and hence ecosystem.   
4.3.4 AMES test results 
Concentrations of the compounds used for AMES test were selected high enough to 
see possible mutagenic effects and low enough to prevent inhibition of bacteria used 
in the test (Table 4.21).   
Table 4.21: Concentrations of the compounds used in AMES test. 
Compound Concentration (µg/L)
Antibiotics  
Amoxicillin 1000 
Ciprofloxacin 1000 
Erythromycin 8 
Sulfamethoxazole 1000 
Β-blockers  
Atenolol 650 
Propranolol 60 
Hormones  
E1 1000 
E2 1000 
E3 1000 
EE2 600 
NSAID  
Diclofenac 1000 
Ibuprofen 220 
Naproxen 106 
Stimulant  
Caffeine 1000 
The selected concentrations were higher than possible environmental concentrations 
to stay at the safe side.  Mixtures for each therapeutic group were tested as well.  In 
antibiotic mixture the concentrations of amoxicillin, ciprofloxacin, and 
sulfamethoxazole were 250 µg/L and 2 µg/L for erythromycin.  In β-blocker mixture, 
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the concentrations of atenolol and propranolol were 325 µg/L and 30 µg/L, 
respectively.  E1, E2, E3, and EE2 concentrations were 250 µg/L, 300 µg/L, 300 
µg/L, and 150 µg/L in the hormone mixture, respectively.  Diclofenac, ibuprofen, 
and naproxen concentrations were 300 µg/L, 70 µg/L, and 35 µg/L in the NSAID 
mixture, respectively.   
All wells of all compounds were purple at the beginning of the test as expected 
(Figure 4.29). 
 
Figure 4.29: Well-plates at the beginning of the AMES test. 
General view of the all samples after 5 day incubation period was provided in Figure 
42. 
After 5 days, some yellow wells indicating mutagenicity were observed (Figure 4.30).  
However, a statistical analysis, fluctuation test, should be conducted to identify a 
compound as mutagen. 
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Figure 4.30: Well-plates after 5 days of the AMES test. 
While no mutation was observed for blank, all wells of negative control were turned 
to yellow meaning strong mutagenicity indicating the solutions used in the test 
contained no mutagen contaminant and the bacteria responding well to a strong 
mutagen (Figure 4.31).  
 
Figure 4.31: AMES results of blank and positive control. 
Some natural (spontaneous) reverse mutations (14 yellow wells) were observed in 
background test (Figure 4.32). 
 
Figure 4.32: AMES results of background. 
14 yellow wells in background plate indicate that some spontaneous mutagenicity 
occurred during the test.  This spontaneous mutagenicity was considered as baseline 
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for tests of compounds and mutagenicity of the compounds were analyzed using 
fluctuation analysis.   
All compounds except ciprofloxacin and sulfamethoxazole had yellow wells in their 
plates (Figure 4.33). 
Yellow wells were counted for each compound (Table 4.22). 
Table 4.22: Positive well counts in AMES test. 
Compound Number of Positive Wells 
Background 14 
Antibiotics  
Amoxicillin 17 
Ciprofloxacin 0 
Erythromycin 14 
Sulfamethoxazole 0 
Β-blockers  
Atenolol 4 
Propranolol 8 
Hormones  
E1 10 
E2 8 
E3 17 
EE2 48 
NSAID  
Diclofenac 9 
Ibuprofen 4 
Naproxen 8 
Stimulant  
Caffeine 8 
Antibiotic mixture 0 
Β-blocker mixture 9 
Hormone mixture 48 
NSAID mixture 10 
According to fluctuation analysis if background has 14 yellow wells, as it is in this 
case, there should be at least 24, 28, and 33 yellow wells in sample plates in order to 
conclude that there is a mutation in 95%, 99% and 99.9% confidence.  In this case 
only EE2 and consecutively hormone mix had mutation effect 99.9% confidence.  
Other compounds tested and their mixtures do not pose mutagenicity hazard in their 
environmental concentrations.  On the other hand, there were more yellow well in 
well plates of E3 and Amoxicillin than background.  Although they cannot be 
designated as strong mutagens according to fluctuation test, they may be considered 
as susceptible compounds. 
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Figure 4.33: AMES test results of the compounds. 
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4.3.5 YES test R-results 
Antibiotics are tested in a concentration range from 50 ng/L to approximately 700 
µg/L which can easily be found in environmental waters (Figure 4.34). 
 
Figure 4.34: YES test results of antibiotics. 
Results obtained from the test were compared with the estrogenic effects of E2.  No 
increase in estrogenic effect was observed at low range concentrations for antibiotics.  
Amoxicillin is the antibiotic which has an estrogenic effect at lowest concentration 
which is 5 µg/L.  However, estrogenicity of amoxicillin does not increase to high 
levels.  Therefore, amoxicillin has low RIE value (5±0.2%).  Other three antibiotics’ 
estrogenic effects start at approximately 10 times higher concentration than 
amoxicillin that 60 µg/L for ciprofloxacin and sulfamethoxazole and 70 µg/L for 
erythromycin.  Ciprofloxacin had the highest RIE value which is 28±3% because of 
the highest estrogenic effect.  Erythromycin and sulfamethoxazole had RIE values as 
9±0.1% and 20±1.7%, respectively.   
A mixture of antibiotics was prepared to test the estrogenic effects of antibiotics 
when they are in mixture (Table 4.23). 
Concentration (ng/L)
1 10 100 1000 10000 100000 1000000
M
ill
er
 U
ni
t
0
10
20
30
40
E2 
Amoxicillin
Ciprofloxacin
Erythromycin
Sulfamethoxazole
 100 
 
Table 4.23: Concentrations of the antibiotics in mixture for YES test. 
Concentration 
Level Amoxicillin Ciprofloxacin Erythromycin Sulfamethoxazole 
1 50 60 70 60 
2 500 600 700 600 
3 5000 6000 7000 6000 
4 50000 60000 70000 60000 
5 500000 600000 700000 600000 
All concentrations are in ng/L. 
Concentrations were selected in the light of YES test results of single antibiotics. 
The estrogenic effect of antibiotic mixture was very similar to the single estrogenic 
effects of antibiotics (Figure 4.35). 
 
Figure 4.35: YES test results of antibiotic mixture. 
Maximum 10.44±1 miller unit estrogenic effect was observed for antibiotic mixture 
at concentration level 5 that corresponding 31±3% RIE.  Although concentration 
level 5 contains highest concentrations tested of each antibiotic, there is not 
statistically difference between RIE of antibiotic mixture and RIE of ciprofloxacin.  
This result indicates no interactive effect occurs among antibiotics for estrogenic 
effects and estrogenicity is dominated by the antibiotic having highest estrogenic 
effect. 
Both of the β-blockers, atenolol and propranolol, are tested in the concentration 
range between 50 ng/L and 500 µg/L (Figure 4.36). 
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Figure 4.36: YES test results of β-blockers. 
Estrogenic effects were observed after 500 ng/L for atenolol and after 5 µg/L for 
propranolol.  Moreover, atenolol had the highest estrogenic effect among β-blockers 
with 16±2% RIE.  Propranolol had 5±0.25 RIE. 
In the light of the single estrogenic effect test, a mixture of β-blockers was prepared 
to measure identify effects (Table 4.24). 
Table 4.24: Concentrations of the β-blockers in mixture for YES test. 
Concentration Level Atenolol Propranolol 
1 50 50 
2 500 500 
3 5000 5000 
4 50000 50000 
5 500000 500000 
All concentrations are in ng/L. 
Mixture of β-blockers had estrogenic effect at low level µg/L concentrations (Figure 
4.37). 
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Figure 4.37: YES test results of β-blocker mixture. 
Estrogenic effect started to be observed from 2nd concentration level in which there 
was 500 ng/L atenolol and 500 ng/L propranolol.  Actually, shape of the mixture 
curve was very similar to atenolol curve.  Moreover RIE of β-blocker mixture was 
17±1 which is not statistically different from RIE of atenolol.  This result indicate 
that highest estrogenic compound dominate estrogenicity of β-blockers when they 
are in mixture. 
NSAIDs were tested to find out their estrogenicity in a concentration range from 55 
ng/L to 835 µg/L (Figure 4.38). 
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Figure 4.38: YES test results of NSAIDs. 
All NSAIDs start to trigger an estrogenic effect after 50 µg/L concentration.  Highest 
impact was observed for ibuprofen with 20±3% RIE.  RIE of diclofenac and 
naproxen are 1.83±0.3 and 3.87±0.3, respectively.   
A mixture of NSAIDs and serial dilutions of that mixture were prepared to observe 
interactive estrogenic effects of NSAIDs (Table 4.25 and Figure 4.39). 
Table 4.25: Concentrations of the NSAIDs in mixture for YES test. 
Concentration 
Level Diclofenac Ibuprofen Naproxen 
1 83.5 75 55 
2 835 750 550 
3 8350 7500 5500 
4 83500 75000 55000 
5 835000 750000 550000 
All concentrations are in ng/L. 
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Figure 4.39: YES test results of NSAID mixture. 
No estrogenic effect was observed until concentration level 5 for NSAID mixture.  
At concentration level 5, RIE was calculated as 21±2.2% which is not statistically 
different from RIE of ibuprofen.  The compound triggering highest estrogenic effect 
for NSIAD mixture (in this case ibuprofen) dominates estrogenic effect of mixture. 
Caffeine was tested for its estrogenic effect at concentrations between 125 ng/L and 
1.25 mg/L (Figure 4.40). 
 
Figure 4.40: YES test results of caffeine. 
Caffeine triggers estrogenic effect after 125 µg/L.  RIE of caffeine was 7±0.9% at 
1.25 mg/L. 
All compounds were mixed according to YES test results of single compounds to 
observe estrogenic effects of the compounds when they are in mixture (Table 4.26). 
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Table 4.26: Concentrations of the compounds in total mixture for YES test. 
Concentration 
Level Amoxicillin Ciprofloxacin Erythromycin Sulfamethoxazole Atenolol Propranolol Diclofenac Ibuprofen Naproxen Caffeine 
1 50 60 70 60 50 50 83.5 75 55 125 
2 500 600 700 600 500 500 835 750 550 1250 
3 5000 6000 7000 6000 5000 5000 8350 7500 5500 12500 
4 50000 60000 70000 60000 50000 50000 83500 75000 55000 125000 
5 500000 600000 700000 600000 500000 500000 835000 750000 550000 1250000 
All concentrations are in ng/L. 
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Estrogenic effect of mixture of all compounds had been observed starting from 
concentration level 2 (Figure 4.41). 
 
Figure 4.41: YES test results of mixture of all compounds. 
Measured effects of mixture of the compounds have some similarities with single 
estrogenicity tests and estrogenicity tests of therapeutic group mixtures.  Estrogenic 
effect started to be observed at concentration level 2 which was the same as 
antibiotic mixture ad β-blocker mixture estrogenicity tests.  Moreover, at that 
concentration level atenolol was 500 ng/L of which the estrogenic effect was 
observed at YES test of atenolol as single compound.  Atenolol was the compound 
showing estrogenic effect at lowest concentration among studied compounds.  At 
concentration level 3, estrogenic effect increases some more where amoxicillin and 
propranolol were 5 µg/L which is the lowest concentration of them showing 
estrogenic effect.  At concentration level 4, estrogenic effect increases some more 
and then reaches to its peak at concentration level 5.  RIE of mixture of all 
compounds was found 32.3±3% which is not statistically different from RIE of 
ciprofloxacin and hence RIE of antibiotics.  Domination of the compounds having 
highest estrogenic effect was also observed for mixture of all compounds at all 
concentration levels.  At concentration level 1, no estrogenic effect was observed.  
Therefore, concentrations of the compounds at that level can be selected as NOEC of 
estrogenicity. 
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5. CONCLUSIONS 
Although pharmaceuticals are very important for the protection of human health, 
they may cause adverse effects in several organisms once they are discharged into 
the environment.  Since pharmaceuticals are designed to exert biological effects, it is 
expected that they adversely affect ecosystem.  Moreover, they may pose threat to 
human health via food web and/or direct exposure.  Therefore, pharmaceuticals in 
the ecosystem must be monitored and their fate and effect mechanisms must be 
identified to protect the integrity of ecosystem and human health.  The first problem 
with these compounds is that their concentrations in receiving waters are too low to 
detect through wet analysis.  Since the information on their occurrence is the starting 
point for the evaluation of their fate and effect in the environment, a rapid and 
sensitive method was developed to measure the concentrations of 14 pharmaceuticals 
and hormones in surface water.  Good peak shapes and chromatographic separation 
preventing cross-talks in MS/MS were achieved with application of ultra-
performance liquid chromatography.  The 1.9 µm-particulate size-column enabled 
low run times and consequently decreased solvent consumption.  With the developed 
method, not only low detection limits (0.1-1 ng/L depending on the compound) were 
achieved but also it is possible to use it to measure compounds having a wide range 
of concentrations from ng/L to µg/L levels.  To sum up, the developed method is one 
of the few in the literature for multi-residue analysis of both pharmaceuticals and 
hormones. 
The method developed during the study was used in order to monitor the presence of 
pharmaceuticals and hormones in a drinking water source: Büyükçekmece Lake and 
its main tributaries (Karasu, Hamza, and Tahtaköprü Rivers; Ahlat and Beylikçayı 
Creeks).  Concentrations and detection frequencies for all/almost all compounds 
were lower in Büyükçekmece Lake than in its tributaries.  The low concentrations in 
Büyükçekmece Lake can be explained by the high volume and retention time of 
water in the lake compared to the rivers.  Among the rivers and creeks, Ahlat and 
Beylikçayı Creeks had the highest pharmaceutical concentrations.  The 
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concentrations of pharmaceuticals were so high that even though they are small 
creeks with rather low flowrates, their contribution to the pollution load to the lake is 
not negligible.   
Most of the pharmaceuticals were detected in high frequencies in rivers and creeks 
with antibiotics and caffeine being the most frequently detected pharmaceuticals.  
The concentrations of pharmaceuticals were different at several orders of magnitude 
with some pharmaceuticals having concentrations below 10 ng/L and some having 
concentrations of 10 µg/L.  Even pharmaceuticals of which only 1% is excreted as 
unchanged compound have been detected in some samples.  Propranolol is an 
example of such compounds and propranolol’s adverse effects to aquatic species at 
low concentrations also suggest the importance of occurrence studies with proper 
analytical techniques. 
There is no wastewater treatment plant discharging treated wastewater into the 
upstream of the sampling points.  Therefore, the presence of such high 
concentrations suggests that there are some uncontrolled wastewater discharges to 
the rivers and creeks.  Therefore, the results of this study indicate that immediate 
measures should be taken for unknown or uncontrolled wastewater discharges in 
Büyükçekmece Watershed. 
The occurrence studies also shed some light on the persistency of pharmaceuticals.  
The measurement results confirm that amoxicillin is prone to degradation in 
environment via natural degradation processes.  On the other hand, ciprofloxacin and 
erythromycin are persistent to degradation.  Considering the persistency of some 
compounds such as ciprofloxacin, continuous loading of pharmaceuticals through the 
creeks may lead to accumulation in the lake and hence may threat the human health 
in addition to the ecosystem, since Büyükçekmece Lake water is used to supply 
drinking water to approximately 2 million people in Istanbul.  
The detection frequency of hormones was lower than the pharmaceuticals.  Among 
the hormones, E3 was detected more and had higher concentrations compared to E1 
and E2. These results support the theory about the conversion of hormones from one 
to other and that E1 and E2 are converted to E3 by natural processes.   
There are fluctuations in concentrations of target compounds from season to season.  
Highest concentrations were observed particularly during July sampling period 
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corresponding to dry weather conditions.  Since seasons have a significant effect on 
the concentration of pharmaceuticals, the need for sampling throughout the year to 
capture any seasonal effect is underlined.  Moreover, this study indicates that 
although the same environmental concentrations are expected within a community 
based on the pharmaceutical and water usage rates, data obtained from different 
sampling points in the watershed may differ significantly. 
In addition to occurrence studies, the possible effects of pharmaceuticals and 
hormones have also been studied.  D. magna acute immobilization test, P. 
subcapitata growth inhibition test, D. magna reproduction inhibition test, AMES test, 
and YES test were conducted to achieve information about acute, chronic, mutagenic, 
and estrogenic effects of pharmaceuticals and hormones.   
Pharmaceuticals and hormones affect D. magna acutely at mg/L concentration levels 
which is unlikely to observe in environmental waters.  On the other hand, P. 
subcapitata was more sensitive than D. magna to pharmaceuticals and hormones.  
Although several compounds such as atenolol, ibuprofen, and caffeine have higher 
EC50 values for P. subcapitata growth inhibition test, their NOECs for P. 
subcapitata growth inhibition test are much lower than D. magna acute 
immobilization test except atenolol.  These results indicate the importance of 
conducting ecotoxicological studies with various species at different levels of the 
food chain.  Since only one effect is not enough to compare and classify 
ecotoxicological analysis, chronic tests were conducted in addition to the acute 
toxicity tests.  D. magna reproduction inhibition test endpoints were at µg/L level for 
all compounds except atenolol for which the endpoint was at mg/L level.  The 
differences observed between acute and chronic effects of pharmaceuticals and 
hormones on P. subcapitata and D. magna indicate that even tough studied 
pharmaceuticals and hormones may not present acute adverse effects at low 
concentrations; they may have drastic chronic effects. 
Although sulfamethoxazole was the most ecotoxic antibiotic according to D. magna 
acute immobilization test, erythromycin was the most ecotoxic antibiotic according 
to P. subcapitata growth inhibition and D. magna growth inhibition tests.  On the 
other hand, amoxicillin induced endocrine disruption at lowest concentration (5 µg/L) 
among antibiotics.  However, ciprofloxacin had highest estrogenic potential with 
28±3% RIE among all tested compounds. 
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Even though P. subcapitata do not have β-receptors suggesting that they may not be 
affected at all by the β-blocker, the effect of propranolol on P. subcapitata was more 
than the acute effect on D. magna.  Therefore, it is possible that there is an additional 
effect mechanism of propranolol other than blocking the β-receptors.  However, 
dissimilar results were observed for atenolol where D. magna is affected more than P. 
subcapitata.  On the other hand, atenolol started to exert an estrogenic effect at 500 
ng/L which is the lowest concentration among all tested pharmaceuticals.   
The hormones studied did not trigger any acute effect to D. magna at bioavailable 
concentrations.  However, they have growth inhibition effect to P. subcapitata and 
reproduction inhibition effect to D. magna.  Although their effects were 
approximately 100 times higher for D. magna chronic toxicity test compared to P. 
subcapitata growth inhibition test at low concentrations, all compounds had similar 
effects to P. subcapitata and to the reproduction of D. magna at higher 
concentrations.  EE2 was the only compound that had any mutagenic effect.   
Among tested NSAIDs, while ibuprofen was the most ecotoxic compound at higher 
concentrations, at lower concentrations naproxen was the most ecotoxic compound.  
This is valid even for different ecotoxicity tests.  Ibuprofen was the most ecotoxic 
NSAID for D. magna acute immobilization and for P. subcapitata growth inhibition 
tests until 1 mg/L concentration.  Naproxen was the most ecotoxic compound for P. 
subcapitata growth inhibition test and D. magna reproduction inhibition test below 1 
mg/L.  The estrogenic effect of all NSAIDs starts after 50 µg/L and they have rather 
lower RIE except ibuprofen with 20±3% RIE. 
No ecotoxic effect is expected for concentrations obtained in samples taken in 
February, March, May and October due to low concentrations of pharmaceuticals 
and hormones in those samples.  On the other hand, concentrations in July are high 
enough to exhibit ecotoxicological effect.  In particular, extremely high ciprofloxacin 
and naproxen concentrations may cause chronic effects on several species.   
Since pharmaceuticals and hormones present in the aquatic environment with other 
pharmaceuticals and hormones, their mixture effects should be identified to get 
information on interactions among these chemicals.  For this purpose, mixtures of 
therapeutic groups and mixtures of all compounds ecotoxicologically tested.   
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Tests conducted with therapeutic group mixtures showed the most interesting results.  
All mixtures had synergistic interaction for D. magna acute immobilization, P. 
subcapitata growth inhibition, and D. magna reproduction inhibition tests.  Moreover, 
mixtures had stronger toxicity than predicted values even at which single compounds 
do not exhibit effects for D. magna acute immobilization, P. subcapitata growth 
inhibition, and D. magna reproduction inhibition tests.  These results indicate that 
NOECs for single toxicity tests are not enough for assessment of environmental risks 
of the compounds.  Hormone mixtures also caused mutagenic effects due to 
mutagenicity of EE2.  Based on the mixture results synergistic interaction of 
amoxicillin, ciprofloxacin, and naproxen is expected in Ahlat in June since the 
concentrations measured are higher than the concentrations used in the mixture to 
determine chronic effects of total mixture.   
For YES test, neither interaction of compounds nor additive effects were observed.  
Estrogenic activity of the mixtures was not statistically different from the compound 
of which has highest estrogenic activity in the mixture which means that highest 
estrogenic compound dominates estrogenicity of mixtures.  Since in all sampling 
periods, Büyükçekmece Lake and some of its tributaries contain hormones, it can be 
concluded that all of the samples in all sampling periods (except Beylikçayı in 
October and Ahlat in July) will exhibit estrogenic effect.   
The occurrence and ecotoxicological data obtained during this study are important 
for environmental risk assessment of pharmaceuticals and hormones.  Particularly, 
the results of mixture tests provide valuable information to risk analysts and decision 
makers as well as to the scientific literature.  Particularly, there is no study in the 
literature reporting D. magna 21d reproduction inhibition test of pharmaceutical and 
hormones and the results obtained in this study will be the first. 
Future works should focus on identifying interactions among more pharmaceuticals 
and endocrine disrupting compounds.  More ecotoxicological tools with higher 
species (e.g., vitellogenin synthesis in male fish and inhibition to embryonic 
development of fish) or macrocosms should be used to identify effects through food 
web and species interactions since it is not possible to extrapolate ecotoxicological 
data from one species to another one. 
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